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CHAPTER 1 
INTRODUCTION 
Poor oocyte quality may be the root cause of infertility or poor reproductive outcomes [1-
4].  Oocyte deterioration results from oxidative stress mediated by enhancement of macrophage 
activity in areas with inflammation, which is known to be involved in the pathogenesis of 
different fertility disorders [2, 5-13].  The deleterious actions of activated macrophages, the 
major source for reactive oxygen species (ROS) such as superoxide (O2•−), hydrogen peroxide 
(H2O2), hydroxyl radical (•OH), and hypochlorous acid (HOCl), as well as the pro-inflammatory 
enzyme myeloperoxidase (MPO), are secondary to their ability to migrate to any site in the 
female genital tract such as fallopian tubes, uterine cavity, and peritoneal cavity as well as their 
cellular effects at the level of the oocyte [8, 14-28].  Indeed, macrophages have been found in the 
cumulus mass surrounding oocytes retrieved from normal healthy woman [23, 26].  Several 
studies have demonstrated that non-activated macrophages excrete growth factors which benefit 
the embryo growth [29].  However, once activated, macrophages have detrimental effects on 
embryo development as well as embryonic pre-implantation, either through enhancement of 
inflammatory pathways or through ROS overproduction [2, 30-33].  Higher levels of MPO and 
ROS, as well as the deficiency of antioxidants such as glutathione and ascorbate,  have been 
found in the peritoneal fluid and follicular fluid of women suffering from chronic inflammatory 
diseases such as endometriosis, polycystic ovary syndrome (PCOS), chronic pelvic infection and 
unexplained infertility,all of which are associated with poor reproductive outcomes [31, 34-43].   
One of the main factors contributing to poor reproductive outcomes is decreased oocyte 
quality [4, 5, 44-46].  Metaphase II (MII) oocytes are known to be exposed to some ROS during 
ovulation [47-50],  however increased levels may impair their proper fertilization, development, 
maturation and compromise the genetic material [1, 2, 7].  The major functional parameters used 
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to assess oocyte quality are spindle microtubule morphology (MT), chromosomal alignment 
(CH)  [5, 8, 11, 51] and organization of the cumulus oocyte complex (COC) [5, 44, 52] as it has 
been established that they can be affected by changes in the oocyte microenvironment such as 
increased ROS [5, 52].  In addition to impairment of oocyte quality, overproduction of ROS can 
cause damage to the cellular proteins, lipids, and DNA [5, 53, 54].  The toxicity of ROS depends 
in part on their bioavailability, rate of production, stability, and the bioavailability of antioxidants 
[5, 8, 55-58]. 
The generation of reactive oxygen species  
Once macrophages are triggered by pro-inflammatory signals, the oxidase activity of 
NADPH oxidase, a plasma membrane enzyme from triggered macrophage cells, begins to 
generate O2•- [5, 8, 19, 59-61].  Superoxide generates H2O2 as an end product non-enzymatically, 
or through superoxide dismutase-catalyzed reaction [19, 59, 62].  The physiological intracellular 
lifetime of H2O2 is moderately long and it is the precursor of the more toxic HO• through a well-
known Fenton reaction (Fe2+ + H2O2 +H+ → Fe3+ + HO• + H2O) [5, 8, 14, 15, 63, 64].  
Hydrogen peroxide is freely diffusible through biological membranes [55, 65], and its 
overproduction is extremely destructive to cells and tissue [5, 64, 66-68].  Hydrogen peroxide 
reacts with MPO, which is abundantly expressed in macrophages, in the presence of chloride (Cl-
) to generate the toxic oxidant HOCl [19-21, 56, 69].  Hypochlorous acid can, in turn, destroy the 
MPO heme moiety causing free iron release, which propagates more oxidant formation such as 
HO• [16, 70].  
Effect of reactive oxygen species on oocyte-cumulus cells complex 
Translational research has shown that patients with inflammatory conditions have higher 
rates of adverse reproductive outcomes through poorer oocyte quality compared to those without, 
suggesting that ROS enhancement may be central to the decrease in fertility potential [2, 4, 5, 71, 
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72].  Indeed, ROS have been shown to decrease the density of the cumulus cells surrounding the 
oocyte, as well as induce cumulus cells apoptosis, which disturbs the defensive antioxidant 
machinery of the cumulus oocyte complex [3, 52, 73].  A variety of antioxidant treatments have 
been studied to mitigate the negative effects of the toxic oxidants [51, 74-77].  Further research 
has suggested that melatonin (MLT), a potent MPO inhibitor and HOCl scavenger, may function 
to protect oocyte quality against oxidative stress (OS) [51].  Since the underlying factors in the 
balance between damaging oxidants and innate and exogenous protective mechanisms in the 
oocyte remain poorly understood, the hypothesis of this dissertation is that ROS and specifically 
MPO related oxidants negatively affect oocyte quality, and that MLT may protect against these 
effects.   
Myeloperoxidase (MPO) and its related oxidants 
Myeloperoxidase, a heme-containing enzyme, is one of the major enzymes secreted upon 
activation of neutrophils and macrophages [19, 20, 69].  
Its molecular mass is ~146 KDa [78].  It is composed of 
two identical subunits connected together by a single 
disulphide bridge, operating the structural design of the 
heme pocket (containing the heme prosthetic group), 
which is the catalytic site of the dimeric form of the 
enzyme [70, 78, 79].  Myeloperoxidase is considered as 
one of the major alternative pathways to generate ROS 
[8, 70].  The catalytic cycle of MPO is depicted in Figure 
1.  In this cycle, a ferryl π cation radical, Compound I (MPO–Fe (IV) = O●+π) is considered to be 
the first intermediate of the reaction of the MPO ferric form, MPO–Fe(III), with H2O2 in the 
presence of chloride (Cl−).  Compound I is converted back to MPO–Fe (III) with the concomitant 
 
Figure 1:  A working kinetic model for the 
competition between H2O2 and HOCl at the 
catalytic site of MPO during steady MPO 
state catalysis [70].  
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two-electron oxidation of Cl− to HOCl [19, 21, 56, 80].  Alternatively, in the absence of Cl−, 
Compound I is converted back to MPO–Fe(III) through a two-step one-electron (1e−) oxidation 
pathway involving organic or inorganic one-electron substrates such as MLT [18, 81, 82].  
Compound II is the catalytically inactive form of the enzyme and the long-lived intermediate in 
the cycle [70]. It can execute only 1e− oxidation reactions.  Thus, formation of HOCl is not 
possible with this intermediate [70].  During inflammation, the amount of HOCl produced from 
activated  neutrophils is around 150−425 μM HOCl/hr, whereas at sites of inflammation, the 
HOCl level is estimated to be as high as 5 mM [83].  Under these circumstances, HOCl can 
damage the host tissue by the same mechanism used to destroy invading pathogens [19, 20, 83].  
Myeloperoxidase, a source of free iron 
Recent studies by Maitra et. al. have demonstrated that MPO may be regulated by 
feedback inhibition via HOCl [70].  The accumulation of the released HOCl in the solution 
mixture permits the competition with H2O2 on the catalytic site of MPO, which in this case is the 
heme prosthetic group resulting in heme destruction and free iron release [70].  It has been 
established that higher MPO activity and HOCl levels, combined with the higher free iron that 
exists in peritoneal fluid of chronic inflammatory diseases such as in advanced stages of 
endometriosis can set the stage for generation of a more toxic molecule, •OH through a known 
Fenton reaction mechanism [8, 39, 84].  The toxicity of HO• and HOCl are mainly due to their 
capacity to participate in serious pathological consequences through cellular mitochondria 
poisoning, lipid peroxidation, and uncoupling of oxidative phosphorylation [14, 85-87].  The 
wide range of MPO properties strongly suggests that MPO is one of the main factors that 
contribute to deteriorate oocyte quality under oxidative stress environment.  The above 
information draws our attention to use MLT as a potent MPO inhibitor and antioxidant scavenger 
to overcome the detrimental effect of oxidative stress on oocyte quality. 
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Melatonin  
Melatonin, a known pineal hormone to regulate circadian rhythms, is secreted in most 
mammalian tissues including the female reproductive tissues such as ovary and follicular fluid 
[76, 77, 88-94].  It has been shown to have multiple properties specifically in the antioxidants 
field compared to other antioxidants [76, 91, 95].  Melatonin has not only a unique ability to 
significantly increase the enzymatic antioxidant gene expression and levels of Cu, Zn-superoxide 
dismutase (SOD), glutathione (GSH) and catalase (CAT)  [76, 77, 90, 95, 96], but also scavenges 
and /or prevents the formation of a variety of ROS such as HOCl and •OH, and inhibits pre 
inflammatory enzymes such as MPO [16, 81] and thus preventing  the oxidation of lipids and  
proteins as well as DNA damage [16, 81, 91].  Not only is MLT characterized by the broad 
spectrum ability to scavenge ROS but its metabolites such as cyclic 3-hydroxmelatonin, N(1)-
acetyl-N(2)-formyl-5-methoxykynuramine (AFMK) and N(1)-acetyl-5-methoxykynuramine 
(AMK) also exhibit multi-antioxidant properties and have no biologically harmful consequence 
similar to MLT [76, 96-103].  Melatonin scavenges HOCl like methionine and taurine but in a 
fundamentally different way [104].  Taurine binds with HOCl to form toxic taurine chloramines 
[105]. Taurine chloramine is a less active oxidant that oxidizes thiols and heme proteins, which 
extend the reactivity of HOCl [105-107].  Furthermore, MLT, unlike other HOCl scavengers, 
displays a high affinity towards transition metal binding (e.g. iron (III), copper and zinc), and 
subsequently reduces their cytoplasmic availability, thus preventing more ROS generation 
mediated by Fenton reaction [108-110].  The capacity of MLT to scavenge •OH is greater than 
other antioxidants such as vitamin E and mannitol [76, 96, 103, 111].  
Along with melatonin’s antioxidants properties, melatonin has shown distinguished anti-
inflammatory effects when it is administered either exogenously in-vivo or when added to 
cultured cells via regulation of cellular pathways [51, 91, 94, 112-117].  Melatonin has the ability 
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through its action on 2 G-protein coupled receptors, MT1 and MT2 to suppress many different 
inflammatory cell types including macrophage cells [114, 115, 117].  Thus, different doses of 
synthetic MLT have been used in medical scenarios in which inflammation plays a role such as a 
weak immune system due to stress, oxidative hemolysis, and even cancer progression [116, 117].  
Melatonin a potent inhibitor of myeloproxidase 
Melatonin has the ability to inhibit MPO chlorinating activity at two different points [16, 
81].  First, it binds to MPO to form the inactive melatonin-MPO-Cl complex [16].  Under these 
circumstances the MPO catalytic activity is limited by the dissociation of melatonin from the 
complex [16, 81].  Second, it competes with Cl- by serving as a 1e- substrate for MPO 
Compounds I and II [16, 81].  Under these conditions, MPO maintains its ability to consume 
H2O2 without the generation of HOCl [16, 56, 81].  Thus, understanding this unique function of 
melatonin on MPO activity may represent a new therapeutic a treatment support to control the 
inflammatory pathways where MPO is elevated.  In addition, melatonin prevents HOCl-mediated 
heme destruction and subsequent free iron release for most hemoprotein compounds including 
MPO [16].    
Melatonin’s role in female reproduction 
Melatonin has been found in the follicular environment surrounding the oocyte [76, 77, 
88-94], which could be the result of the pumping activity of channels located in the follicular 
wall; therefore, its antioxidant properties could benefit the oocyte.  Clinical prospective trials 
have found an increase in the pregnancy rate for a group of women suffering from PCOS when 
their treatment regimen was supplemented with MLT compared to a group who did not receive 
melatonin [77, 118, 119].  Clear direct evidence linking MLT supplementation with oocyte 
quality improvement have recently been provided through the demonstration that a significant 
decrease in the ROS level improved oocyte maturation in oocyte media supplemented with MLT 
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Figure 2: Image of cumulus oocyte complex (COC)
obtained using Confocal Zeiss LSM 510 META
NLO microscope. Control COC with normal
microtubule (MT) and chromosomal (CH) alignment
with a good organization of cumulus cells (CC’s)
surrounding the oocyte. Scale bars: 1 pixel, 3 mm.
Results depict observations made after three
experiments. 
compared to those without MLT [91, 120-122].  Furthermore, MLT (1mM) supplemented media 
of murine oocytes collected 8 hours after ovulation showed a significant increase in the 
percentage of fertilization [123].  Recently, it has been shown that MLT has the ability to protect 
the spindle’s morphology when exposed to higher concentrations of HOCl [51].  
Microtubule and chromosomal alignment marker for oocyte quality 
Several markers for oocyte quality have been used to evaluate deterioration in the 
postovulatory MII oocyte quality using in-vitro studies such as zona pellucid a dissociation time 
(ZPDT), oocyte microtubular dynamics (OMD), and cortical granule (CG) degradation, as 
oocyte aging markers [4, 5, 44].  Oocytes at MII phase, the arrested stage of ovulated oocyte 
before fertilization, demonstrated a dense array 
of filaments with bundles forming the meiotic 
spindle [124-126].  Moreover, this is the stage 
where the meiotic spindles are attached with the 
chromosomes at the equator of the spindles 
[124-127]. 
In mammals, the oocyte is typically 
surrounded by numerous layers of cumulus 
cells (CC’s), derived from the granulosa cells 
(GCs), forming the COC (cumulus oocyte 
complex) [23, 73, 128] (Figure 2).  Their 
presence in sufficient numbers and organization 
may serve as a predictive marker for oocyte quality [23, 73, 128].  The cumulus cells provide 
several important functions to the oocyte such as protection, and nutrient delivery through their 
gap junction proteins channels, a network of intercellular membrane channels mediating 
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communication within the COC [23, 73, 129-131].  The oocyte, under pathological conditions, 
protects itself against the toxicity of ROS through enzymatic (e.g., catalase and glutathione 
peroxidase) and nonenzymatic antioxidants (e.g., ascorbic acid and reduced glutathione) 
provided by the surrounding CC’s [132, 133].  Increases in the rate of fertilization and early 
embryo development have been found when the human oocyte or the embryo had been cultured 
in the presence of cumulus cells [134].  Therefore, derangements in COC organization, cumulus 
cell number, and cumulus-cumulus cell interaction through staining of the gap junction protein, 
connexin 43, were the parameters used to determine the mechanism of oocyte quality 
deterioration secondary to direct ROS insult.  
Despite the structural simplicity of COC, preserving the intact communication between 
the oocyte and its surrounding CCs is important to the oocyte to withstand the unstable 
environment, namely OS, which may negatively impact oocyte quality [52, 135]. 
In this study we focus on the use of meiotic spindle structure, MT and CH, as an 
important oocyte quality marker 
because they are essential for proper 
oocyte division and subsequent embryo 
formation [11, 136, 137].  Moreover, 
spindle disruption will lead to improper 
CH segregation leading to an imbalance 
in the genetic material of the daughter 
nucleus with detrimental effect on fertility as well as in assisted reproduction outcomes [137].  
We and others have developed a 1-4 scoring system depending on the oxidative damage effect 
on the meiotic spindle structure, MT and CH, as an important oocyte quality marker (Figure 3) 
[8, 11, 51, 52].  Briefly, a good spindle configuration was coded for (score 1, 2) where 
Figure 3: Schematic diagram demonstrating scoring 
system of MT and CH alteration based on previous study 
by Choi et al and Banerjee et al [8, 11, 51] 
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microtubules were organized in a barrel-shape, whereas, abnormal or poor (score 3, 4) were for 
spindle length reduction, disorganization and complete absence of spindle.  Chromosomal 
configuration was considered as good (score 1, 2) when chromosomes are normally arranged at 
the equator of the spindle, while poor (score 3, 4) when the chromosomes are dispersed or show 
aberrant or less condensed appearance [8, 11, 51, 52].  Studying oxidative stress-mediated 
spindle structural damage could serve as a feasible approach for further assessments to search for 
the therapeutic options to preserve the good quality for the oocyte under inflammatory states.  
Aims of dissertation: 
1) Determine the direct effect of ROS on metaphase II mouse oocyte quality  
2) Determine the effect of MPO (purified and naturally secreted from activated 
macrophages) related oxidants on metaphase II mouse oocyte quality and whether 
melatonin can protect against this effect. 
3) Define the mechanism of melatonin protection. 
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CHAPTER 2  
THE DEFENSIVE ROLE OF CUMULUS CELLS AGAINST REACTIVE OXYGEN 
SPECIES INSULT IN METAPHASE II MOUSE OOCYTES 
(This chapter contains previously published material. See Appendix A) 
Abstract 
We investigated the ability of reactive oxygen species (ROS), such as hydrogen peroxide 
(H2O2), hydroxyl radical (•OH), and hypochlorous acid (HOCl) to overcome the defensive 
capacity of cumulus cells, and elucidate the mechanism through which ROS differentially 
deteriorate oocyte quality.  Metaphase II mouse oocytes with (n=1634) and without cumulus 
cells (n=1633) were treated with increasing concentration of ROS and the deterioration in oocyte 
quality was assessed by the changes in the microtubule morphology (MT) and chromosomal 
alignment (CH).  Oocyte and cumulus cell viability and cumulus cell number were assessed by 
indirect immunofluorescence, staining of gap junction protein, and trypan blue staining.  The 
treated oocytes showed decreased quality as a function of increasing concentrations of ROS as 
compared to controls.  Cumulus cells show protection against H2O2 and •OH insult at lower 
concentrations, but this protection was lost at higher concentrations (>50 μM).  At higher H2O2 
concentrations treatment dramatically influenced the cumulus cell number and viability with 
resulting reduction of the antioxidant capacity making the oocyte more susceptible to oxidative 
damage.  However, cumulus cells offered no significant protection against HOCl at any 
concentration used.  In all circumstances in which cumulus cells did not offer protection to the 
oocyte, both cumulus cell number and viability were decreased.  Therefore, the deterioration in 
oocyte quality may be caused by one or more of the following: a decrease in the antioxidant 
machinery by the loss of cumulus cells, the lack of scavengers for specific ROS, and/or the 
ability of the ROS to overcome these defenses. 
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Introduction 
Oocytes are surrounded by tightly packed, highly organized layers of cumulus cells 
(CCs) that exist in spatial and temporal heterogeneity, forming the cumulus-oocyte complex 
(COC) [23, 73, 128].  In addition to their role in providing nutrition to the oocyte, the CCs 
provide a communication network between the oocyte and its extracellular microenvironment 
[23, 73, 129, 130].  The manner through which CC’s communicate within the COC are 
specialized connections called gap junctions, which are aggregates of protein-based intercellular 
channels that directly connect adjacent cells, allowing the bi-directional movement of molecules 
[131].  These channels known as connexins (Cx) have been described in many tissues; however 
Cx 37 is the only one identified on the oocyte, and forms connection with CC’s, while Cx 43 is 
the main gap junction protein found on CC’s. Loss of Cx proteins has been attributed to 
disrupted folliculogenesis, CC dysfunction, and altered cell and tissue viability [131, 138-140].  
Therefore, Cx’s are critical as they function as primary means of disseminating information to 
and from the oocyte, and also serve the important function of anchoring the CC’s within the 
COC to protect the oocyte.  It is known that oocytes, under pathological conditions, protect 
themselves against the toxicity of reactive oxygen species (ROS) through a scavenging 
enzymatic (e.g., catalase and glutathione peroxidase) and nonenzymatic antioxidant (e.g., 
ascorbic acid and reduced glutathione) network provided by the surrounding CC’s [132, 133].  
Translational research has shown that patients with these conditions have higher rates of adverse 
reproductive outcomes and poor oocyte quality compared to those without such disorders 
suggesting that inflammation may be central to the decrease in fertility potential [2, 4, 5, 71, 72].  
Reactive oxygen species such as superoxide (O2•−), hydroxyl radical (•OH), hydrogen 
peroxide (H2O2), and hypochlorous acid (HOCl) are highly disruptive to cellular function [5, 8, 
51].  The major intracellular sources of H2O2 are spontaneous production, superoxide dismutase-
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catalyzed reaction of O2•− [62, 141], generation through the mitochondrial electron transport 
chain, and the NADPH oxidase system in the cellular plasma membrane [5, 66, 142].  Hydrogen 
peroxide is found in physiologic concentrations ranging from 10-20 μM and up to 100 μM in 
pathologic circumstances [143].  Exposure of mouse oocytes to higher H2O2 concentrations (200 
μM) completely inhibited cleavage, and caused arrest of the zygote at the 1-cell stage [144].  A 
link between the concentration of endogenous H2O2 and the occurrence of apoptosis in human 
embryos has been suggested [144-147].  There are other ways that H2O2 can indirectly affect 
oocyte quality, for example, we have recently shown that •OH generated by the H2O2-induced 
Fenton reaction caused instantaneous oocyte damage, which has been estimated indirectly in 
plasma at levels of 250-500 μM/L [8, 148].  More recently we have demonstrated that the 
diffused intraoocyte H2O2 in the presence of chloride, which are normally found in the oocyte 
and oocyte microenvironment respectively, can trigger the catalytic activity of MPO generating 
the toxic oxidant, HOCl [58, 141], a substance known to deteriorate oocyte quality [51].  
Activated neutrophils, the major cellular releaser of MPO, generate around 150−425 μm 
HOCl/hr, whereas at sites of inflammation, the HOCl level is estimated to reach as high as 5 mM 
[83].  Previously, it has been shown that higher levels of MPO exist in the peritoneal and 
follicular fluid of women with inflammatory conditions such as endometriosis [39, 43]. 
Macrophages, neutrophils and monocytes are the major cellular sources of MPO, which function 
to generate HOCl and other ROS [20].  The current study investigates the ability of the 
antioxidant system of the CC’s to deflect the H2O2-mediated oxidative damage from mouse 
oocytes, and highlights the mechanism through which H2O2 deteriorates oocyte quality.  Our 
results provide a previously undescribed mechanistic link between excess H2O2 accumulation 
and poor oocyte quality, namely, through the disassembly and decreased viability of the 
protective CC cloud, which allows the dismantling of the spindle and chromosomal alignment.  
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These effects may cause poor oocyte quality and thus poor reproductive outcomes, which are 
associated with various inflammatory conditions.  
Materials and Methods 
Materials 
All the materials used were of the highest grade of purity and without further purification. 
Hydrogen peroxide, sodium hypochlorite (NaOCl), ammonium ferrous sulfate (Fe(II)), Human 
tubular fluid (HTF) media, anti-α tubulin antibody, FITC conjugate anti-goat antibody, 
propidium iodide, 1% BSA (Bovine Serum Albumin), 0.1% M Glycine, and 0.1% Triton X- 100 
were obtained from Sigma–Aldrich (St. Louis, MO, USA).  Normal Goat Serum (2%) was from 
Invitrogen (Grand Island, NY) and 0.2% Powder Milk from grocery.  Metaphase II oocytes (with 
and without cumulus cells) from a B6C3F1 mouse crossed with a B6D2F1 mouse were obtained 
commercially (Embryotech Inc.) in cryopreserved straws using ethylene glycol-based slow 
freeze cryopreservation protocol.  We used mature MII oocytes for the purpose of understanding 
the defense rendered by the cumulus cells at the mature cell stage level.  Though it is understood 
that there may be some loss of antioxidant defense during the expansion as a physiologic 
mechanism for preparation for ovulation, we believe that pre-existence of intact gap junctions for 
delivery of antioxidant defense is essential for prevention of spindle damage during maturation 
process in inflammatory states.  It is known that the oocyte spindle repolymerizes to normal 
structure when incubated in media for 60 -120 min at 37°C and 5% CO2 [149, 150] prior to 
induction of oxidative stress.  This mechanism actually has helped support utilization of frozen 
oocytes for studying spindle damage.  The use of frozen-thawed oocytes is well accepted as 
many studies have been published in the past utilizing frozen thawed oocytes and effects of 
oxidative stress on spindle morphology [151, 152]. 
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Methods 
Metaphase II mouse oocytes with and without cumulus cells, in triplicate for each ROS 
experiment, were transferred from straws to phosphate buffer saline (Dulbeco’s PBS) and 
washed to remove excess cryoprotectant for 3 minutes.  Oocytes were then transferred to HTF 
media and incubated at 37º C and 5% CO2 for 60 minutes to allow spindle repolymerization and 
attainment normal oocyte architecture [153, 154].  The oocytes were then screened for the 
presence of the polar body confirming their Metaphase II stage.  Ten – twenty oocytes from each 
group were discarded as they were found to be immature or displayed disrupted zona pellucidas.  
In each ROS experiment metaphase II oocytes with and without cumulus cells were divided into 
three groups: H2O2, •OH, and HOCl treatments. 
For H2O2 treatment (experiments performed in triplicate), oocytes were divided into four 
different groups; (group 1, n=620) oocytes without cumulus cells incubated with increasing 
concentrations of H2O2 (10, 17, 25, 50 and 100 µM); (group 2, n=611) Oocytes with cumulus 
cells incubated with increasing concentrations of H2O2 (10, 17, 25, 50 and 100 µM); (group 3, 
n=62) untreated oocytes with and (group 4, n=62) without cumulus cells.  
For •OH treatment (experiments performed in triplicate), oocytes were divided equally 
into eight groups: oocytes with (group 1, n=171) and without (group 2, n=171) cumulus cells 
treated with increasing concentrations of H2O2 (5, 10, 20 µM); oocytes with (group 3, n=60) and 
without (group 4, n= 61) cumulus cells treated with a fixed concentration of Fe(II) (100 µM);  
oocytes with (group 5, n= 173) and without (group 6, n= 191) cumulus cells pre-incubated with a 
fixed concentration of  Fe (II) (100 µM) and treated with increasing concentrations of H2O2 (5, 
10, 20 µM) under these circumstances all H2O2 was converted to •OH; and untreated oocytes 
with (group 7, n= 60) and without (group 8, n= 73) cumulus cells.  Due to the instability of •OH 
and its instant effect on oocyte quality, all sets were exposed for less than 10 minutes.  This short 
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incubation time also eliminates the effect of H2O2 and Fe(II) alone as previously described [8].  
The concentration of Fe (II) (100 µM) used in the current study to establish the •OH generating 
system has been widely used in previous studies [155]. 
For HOCl treatment (experiments performed in triplicate), oocytes were divided into four 
different groups: (group 1, n=324) oocytes with cumulus cells and (group 2, n=391) oocytes 
without cumulus cells treated with increasing concentrations of HOCl (10, 25, 50 and 100 µM); 
and (group 3, n=73) untreated oocytes with cumulus cells and (group 4, n=64) untreated oocytes 
without cumulus cells.  The treated and untreated oocytes were incubated with HOCl for 15 min 
to ensure maximum effect. 
Immunofluorescence staining and fluorescence microscopy 
All treated and untreated oocytes were fixed in a solution prepared from 2% 
formaldehyde and 0.2 % Triton X-100 for 30 minutes at 25° C [3].  The fixed oocytes were 
treated with blocking solution (PBS, 0.2% Powdered Milk, 2% Normal Goat Serum, 1% Bovine 
Serum Albumin (BSA), 0.1 M Glycine and 0.1% Triton X-100) for 30 minutes then washed with 
PBS for 3 minutes [3, 8].  Subsequently, the oocytes were subjected to indirect 
immunofluorescence staining by incubating in mouse primary anti-α tubulin antibody against the 
MT for 60 minutes and secondary fluorescein isothiocyanate (FITC) conjugated anti-goat 
antibody for 30 minutes [3].  The chromosomes were stained using propidium iodide (PI) and 
incubated for 15 minutes [3].  Stained oocytes were loaded into an anti-fade agent on slides with 
two etched rings and cover slips were affixed using nail varnish.  The alterations in the MT and 
CH were compared with controls and scored by three blinded observers based on a previously 
published scoring system (Figure 2) [11, 126].  Scores of 1-4 were assigned for both MT and CH 
alterations, with scores 1 and 2 combined for good outcomes meaning microtubules were 
organized in a barrel-shaped with slightly pointed poles formed by organized microtubules 
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crosswise from pole to pole, and chromosomes were normally arranged in a compact metaphase 
plate at the equator of the spindle [11, 126].  Scores of 3 and 4 signified poor outcomes and 
consisted of spindle length reduction, disorganization and/or complete spindle absence, and 
chromosome dispersion or aberrant condensation appearance [11, 126].  Images were obtained 
utilizing both immunofluorescence and confocal microscopy. 
Confocal microscopy, assessment of microtubules and chromosomal alignment 
Slides were examined with the Axiovert 25 inverted microscope (Zeiss, Thornwood, NY) 
using Texas Red (red) and FITC (green) fluorescent filters with excitation and emission 
wavelengths of 470 and 525 nm, and 596 and 613 nm, respectively.  Confocal images were 
obtained utilizing a Zeiss LSM 510 META NLO (Zeiss, Germany) microscope.  Oocytes were 
localized using a 10 x magnification lens and spindle alterations assessed using 40 x oil 
immersion lens.  The MT was stained fluorescent green, which was distinct from the fluorescent 
red staining of the chromosomes.  Following completion of the experiments each oocyte was 
closely examined for spindle status by three independent observers blinded to the assigned 
treatment groups.  Observers used comprehensive evaluation of the individual optical sections 
and the 3-D reconstructed images. 
Viability assay (Measurement of COC viability):  
We used oocytes with cumulus cells (n=100) exposed to 10 and 25 µM of each ROS 
before fixing followed by addition of 10 µL of trypan blue dye (Sigma) into the HTF media for 4 
minutes.  The untreated oocytes were also subjected to trypan blue dye to determine the number 
of viable cells (the dye exclusion test) in the media.  This test is based on the fact that living cells 
possess intact cell membranes that will keep out certain dyes (trypan blue and propidium), 
whereas dead cells will not. Both control and exposed groups were examined under the Axiovert 
25 light microscope and cumulus cells were counted for staining with images obtained. 
17 
 
Connexin 43 immunostaining and fluorescence confocal microscopy:  
In this experiment, we grouped the metaphase-II mouse cumulus oocytes (n=30) in two 
sets in the HTF culture media, A) control cumulus oocytes, B) cumulus oocytes incubated with 
100 µM H2O2 oocytes for 45 minutes.  Then as mentioned before, oocytes were fixed in a 
solution prepared from 2% formaldehyde and 0.2 % Triton X-100 for 30 minutes.  The fixed 
oocytes were treated with blocking solution as previously described for 1 hour, and then washed 
with PBS for 3-5 minutes.  Subsequently, the oocytes were subjected to indirect immunostaining 
for connexin 43 (Cx 43) by incubating them in Monoclonal Anti-Connexin-43 antibody 
produced in mouse (1:100) ((C8093) from Sigma-Aldrich) over night at 4ºC follow by secondary 
FITC conjugated antigoat antibody (1:50) for 30 minutes (green color).  The chromosomes were 
stained using propidium iodide (1:50) by incubating for 15 minutes to count the granulosa cells 
before and after H2O2 treatment.  Stained oocytes were loaded into an antifade agent on slides 
with two etched rings and cover slips were placed using nail varnish.  
Solutions preparation 
The H2O2 solution was prepared fresh in phosphate buffer (PH 7.4), while the 
concentrations of the working solutions were determined spectrophotometrically (extinction 
coefficient of 43.6 M-1 cm-1 at 240 nm) [156, 157]. 
The HOCl was prepared as previously described with some modifications [158].  Briefly, 
a stock solution of HOCl was prepared by adding 1 ml of NaOCl solution to 40 ml of 154 mM 
NaCl and the pH was adjusted to around 3 by adding HCl.  The concentration of active total 
chlorine species in solution, expressed as [HOCl]T (where [HOCl]T = [HOCl]+ 
[Cl2]+[Cl3−]+[OCl−]) in 154 mM NaCl, was determined by converting all the active chlorine 
species to OCl− by adding a bolus of 40 μl of 5 M NaOH and measuring the concentration of 
OCl−.  The concentration of OCl− was determined spectrophotometrically at 292 nm (ε = 362 
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M−1 cm−1).  As HOCl is unstable, the stock solution was freshly prepared on a daily basis, stored 
on ice, and used within 1 hr of preparation.  For further experimentation, dilutions were made 
from the stock solution using 200 mM phosphate buffer, pH 7.0, to give working solutions of 
lower HOCl concentrations [70].  During and after the preparation process, all solutions were 
kept on ice to minimize decomposition. 
Statistical analysis:  
Statistical analyses were performed using SPSS version 22.0 (SPSS Inc., Chicago, IL, 
USA).  One-way ANOVA procedures were performed to compare the percentage of oocytes 
with poor outcomes (scores 3 and 4) for MT and CH between controls and oocytes treated with 
various oxidants concentrations.  No transformation was used because a good portion of the data 
ranged between 0.2 and 0.8.  The Tukey’s post-hoc procedure was used for pairwise 
comparisons among treatment groups. Statistical significance was indicated by P< 0.05.  
Independent t-tests were conducted to compare the cumulus and non-cumulus oocytes for each 
oxidant concentration. 
Results 
Effect of ROS on cumulus enclosed and denuded oocytes 
The majority of both cumulus-enclosed and denuded control oocytes had good-scores 
(98% and 90% respectively) (Figure 4).   
Exposure to H2O2, •OH, and HOCl resulted in various detrimental effects on oocyte 
quality, as assessed by the poor scoring of MT and CH. These detrimental effects depended on 
the presence or absence of cumulus cells, relative strength of the oxidizing agent, and its 
concentration. 
As shown in Figure 4 A and Figure 5 (upper panel), in the absence of cumulus cells, 
increasing H2O2 concentrations (10, 17, 25, 50 and 100 µM) were associated with significant 
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increases in poor scores of MT (45%, 74.4%, 93.5%, 100% and 100% respectively) (p< 0.001).  
In contrast as shown in Figure 5 lower panel, in the presence of cumulus cells, the frequency of 
poor MT scores also increased when subjected to similar concentrations of H2O2, but to a lesser  
extent: 19.8% (p>0.05), 33.9% (p<0.05), 46.7% (p<0.001), 96.7% (p<0.001) and 100% 
 
Figure 4: The effect of increasing concentration of H2O2, •OH, and HOCl on MT of metaphase-II 
mouseoocytes in the absence (gray bars) and the presence (green bars) of cumulus cells. (A) The percentage 
of oocytes with poor scores in MT treated with 0, 10, 17, 25, 50 and 100 µM H2O2. (B) The percentage of oocytes 
with poor scores in MT treated with 0, 5, 10, and 20 µM •OH.  (C) The percentage of oocytes with poor scores in 
MT treated with 0, 10, 25, 50 and 100 µM HOCl. One-way ANOVA and independent t-test employing SPSS 21.0 
were used for statistical analysis. ap< 0.05 non-cumulus oocytes as compared to control, bp< 0.05 cumulus 
oocytes as compared to control, and cp< 0.05   cumulus compared to non-cumulus oocytes at each concentration. 
The experiments were conducted with three replications; the error bars represent the standard error of the mean. 
 
Figure 5: Images showing the effect of different H2O2 concentrations on oocyte quality obtained using 
Confocal Zeiss LSM 510 META NLO microscope. (A) Control oocyte without cumulus cells with normal 
MT and CH. (B) Oocyte without cumulus cells with altered MT and CH exposed to 25 µM H2O2. (C) 
Oocyte without cumulus cells treated with 50 µM H2O2. (D) Control oocyte with cumulus cells with normal 
MT and CH. (E) Oocyte with cumulus cells with normal MT and CH exposed to 25 µM H2O2. (F) Oocyte 
with cumulus cells treated with 50 µM H2O2 with altered MT and CH.  Scale bars: 1 pixel, 5 mm for images 
A–C and 1 pixel, 3 mm for images D–F. Red arrows show the MT and the CH alterations.  The experiments 
were conducted with tree replications. 
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(p<0.001), respectively (Figure 4A and Figure 5).  Similar results were observed for CH. A 
similar trend was observed for oocytes treated with increasing concentration of H2O2 in the 
presence of fixed amounts of Fe(II) (100 µM).  Under these circumstances, H2O2 was 
immediately converted to •OH in a 1:1 ratio [8].  Poor scores of MT were higher in the non-
cumulus groups at 5, 10, and 20 μM (80.3%, 92.2% and 96.6% respectively (p<0.001)) 
compared to oocytes with cumulus cells (10.5% (p>0.05), 49.8% (p<0.001) and 56.6% (p<0.001) 
respectively) suggesting cumulus cell protection (p<0.001) (Figure 4B).  In contrast to H2O2 and 
•OH, non-significant independent t-tests revealed that cumulus cells do not offer protection 
against HOCl at concentrations of 10-100 μM (Figure 4C).  Poor scores were noted following 
increasing HOCl concentrations (10, 25, 50, 100 μM) for both cumulus (20.7%, 57.9%, 66.1% 
and 100% respectively) and non-cumulus oocytes (30%, 58.3%, 64.6% and 100%, respectively) 
compared to controls (p<0.001).  Thus, antioxidant machinery provided by cumulus cells may 
have selective protection against ROS. 
Effect of ROS on cumulus cell number, dispersion, and connexin 43  
To determine the mechanism by which different concentrations of ROS overwhelm the 
protective antioxidant machinery provided by cumulus cells, we next investigated the effect of 
increasing concentrations of H2O2, •OH, and HOCl on COC organization, cumulus cell number, 
and cumulus-cumulus cell interaction through staining of gap junction protein, connexin 43, 
utilizing confocal imaging as well as cumulus oocytes viability using trypan blue dye exclusion 
method.  
As shown in Figure 6A, untreated oocytes were surrounded by tightly packed highly 
organized layers of cumulus cells.  After treatment with lower concentrations of H2O2 (<25 µM) 
the COC remained intact and organized with similar number of cumulus cells observed as 
compared to controls, reflecting the preservation of oocyte quality (Figure 5B and C).  Treatment 
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with high H2O2 concentrations changed the organized compact cumulus cell mass into a 
dispersed structure of cells (Figure 6D).  In some cases, these clouds of cumulus cells are small, 
scattered, and remain loosely linked to the oocyte (Figure 6).  Collectively, these alterations in 
the oocyte microenvironments upon exposure of the oocytes with cumulus cells to higher ROS 
concentrations could explain the damaging effect of H2O2 and •OH to oocyte quality.  
 
Figure 6: Images of cumulus-oocyte complexes as a function of increasing concentrations of H2O2 obtained 
using amicroscope-mounted Axiocam camera with Axiovision software (Zeiss).  Panel A is a control of COC 
with normal MT, CH, and good organized cluster of cumulus cells surrounding the oocyte. Panels B-D oocytes 
treated with 10, 25, and 50 µM H2O2, respectively.  Scale bar: 1 pixel, 2 mm. The experiments were conducted with 
tree replications. 
 
As shown in Figure 7A, the control COC, stained for Cx 43 (green) and CH (red), 
showed organized clustering of cumulus cells surrounding the oocyte. Oocyte with cumulus cells 
exposed to a higher H2O2 concentration (e.g. 100 µM) showed significant decrease in the 
cumulus cells number or in some cases complete removal of the cumulus cells compared with 
untreated COCs (data not shown).  However, the intensity of Cx 43 staining appears similar to 
control.  
Figure 7: Metaphase-II mouse cumulus 
oocyte complexes (COCs) images 
obtained with Confocal Zeiss LSM 510 
META NLO microscope showed the 
effect of H2O2 on Connexin (Cx) 43 
density (n=20). A) Control COC stained for 
Cx 43 (green) with CH (red) with organized 
clustering of cumulus cells surrounding the 
oocyte. (B) COC exposed to 100 µM of 
H2O2 with significant decrease in the 
cumulus cells number with decrease in Cx 
43 staining compared with untreated COC. 
Results depict observations from three 
experiments.  Scale bar: 1 pixel, 2 mm. 
 
22 
 
Finally, the trypan blue dye exclusion method was used to determine the viability of the 
cells after exposure to HOCl, and to explain the failure of cumulus cells to protect oocyte against 
HOCl.  Oocytes without cumulus cells exposed to higher HOCl concentrations (>25 µM) had a 
higher intensity of staining compared with untreated controls and oocytes exposed to lower 
concentrations of HOCl (Figure 8, upper panels).  
 
Figure 8: Images of oocytes without (upper panel) and with (lower panel) cumulus cells as a function of 
increasing concentrations of HOCl obtained using a microscope- mounted Axiocam camera with Axiovision 
software (Zeiss).  Trypan blue viability staining with increased stain uptake in oocytes exposed to 0, 10, 25, 50, and 
100 µM HOCl).  Scale bars: 1 pixel, 4 mm for images A–C and 1 pixel, 2 mm for images D–F. The experiments 
were conducted with tree replications. 
Cumulus oocytes showed greater intensity of staining and significant decrease in cumulus 
cell number at higher concentrations of HOCl, specifically at 100 µM (Figure 8 lower panels).  
This signifies that exposure to HOCl rendered the cumulus cells nonviable, which could explain 
the failure of the cumulus cells to provide antioxidant defense as trypan blue staining was similar 
between cumulus and noncumulus oocytes (Figure 8).  Collectively, the mechanism through 
which cumulus cells lose their ability to defend against the effects of ROS is largely through the 
partial or complete loss of cumulus cells, which can be explained by the loss of cumulus cell 
viability. 
Discussion 
In this work, we investigated the ability of cumulus cells to protect the oocyte against 
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ROS and elucidate the mechanism and details of this action.  Our results showed that oocytes, 
with and without the surrounding cumulus cells, treated with increasing concentrations of 
various ROS exhibited deterioration in oocyte quality as a function of concentration, when 
compared to untreated controls.  Cumulus cells demonstrated protection against H2O2 and •OH 
insult at low concentrations, but this protection was lost at higher concentrations.  Cumulus cells 
offered no statistically significant protection against HOCl at any concentration.  In all 
circumstances in which cumulus cells did not offer protection to the oocyte, both cumulus cell 
number and viability were decreased as judged by confocal immunofluorescence and viability 
staining.  Collectively, the deterioration in oocyte quality may be caused by a decrease in the 
antioxidant machinery of the COC by loss of cumulus cells or the lack of scavengers for specific 
ROS, and/or the ability of the ROS to overwhelm these defenses.    
Hydrogen peroxide is known to generate cellular toxicity both independently and through 
its involvement in the production of other ROS [63, 85, 141].  Hydroxyl radical, produced by the 
H2O2-driven Fenton reaction, is known to be associated with disorders of iron overload, such as 
endometriosis and hemochromatosis, in which reproductive failure linked to oxidative stress is 
common [8, 63, 159-161].  Our current investigation supports the notion that CC’s, the major 
components of the cellular layers directly surrounding the oocyte, provide protection against 
ROS only to a certain extent.  Indeed, oocyte exposure to low concentrations of H2O2 in the 
absence or in the presence of Fe(II), where H2O2 is instantly converted to  •OH, induced little or 
no effect on the organized arrangement of surrounding cumulus cells.  Under these 
circumstances, the oocyte’s protection against H2O2/•OH insult is due to the antioxidant 
machinery provided by the cumulus cells rather than that provided locally by the oocyte.  This 
conclusion is based on a significant decrease in the percentage of oocytes with poor scores in the 
presence versus absence of cumulus cells as a function of increasing concentration of H2O2/•OH 
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(Figure 2 A & B).  In addition to a number of non-enzymatic small molecule antioxidants that 
are known to be present in the intact COC, there are a number of enzymes responsible for H2O2 
detoxification including catalase, glutathione peroxidase and peroxiredoxin [162-166].  These 
enzymes display the capacity to scavenge lower concentrations of both H2O2/•OH and protect the 
oocytes from their damaging effects [162, 163, 165].   
We have also shown that treatment with high H2O2 and •OH concentrations changed the 
organized compact cumulus cell mass into a dispersed structure of cells.  With high but 
physiological concentrations of these oxidants the compact clouds of cumulus cells are scattered 
and remain loosely linked to the oocyte.  At pathological H2O2 and •OH concentrations, the 
cumulus cells are stretched further and finally disconnected from the oocyte.  Once the cumulus 
cells are dispersed or disconnected from the oocyte, the oocyte has lost its protection and 
therefore becomes as susceptible to ROS insult as non- cumulus oocytes [73, 167].  The loss of 
CC protection is due to the partial or complete loss of cumulus cell number, which could be 
caused by either the loss of cumulus cell viability or by the disruption of cumulus cell-cell 
interactions (Cx 43).  Our results show the major factor is the loss of cumulus cell viability, 
which may explain the mechanism for oxidative stress associated reproductive failure. 
Hydrogen peroxide is also known to be involved in the production of HOCl mediated by 
MPO [58, 70, 141].  At all concentrations tested, HOCl treatment was harmful and directly 
affected the viability and the number of cumulus cells through its ability to react with a range of 
biological molecules, particularly those with thiol, thiolether, heme proteins, and amino groups 
leading to tissue injury [168, 169].  Recently we showed that HOCl, in a feedback mechanism, 
degraded the heme-ring in MPO which released free iron [70] and led to •OH generation [8, 63].  
In contrast to treatment with H2O2 and •OH, CC’s showed no significant sign of protection 
against HOCl at any concentration.  We have recently shown that ONOO-, like HOCl, mediates 
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damage to MT and CH alignment [3].  After exposure to both reagents, cumulus cells were 
stripped from the oocyte and oocyte viability was significantly compromised.  Such compromise 
could occur either due to the deficiency of specific enzymatic and non-enzymatic antioxidants 
that help to scavenge ROS throughout the female reproductive tract [74, 170].  
The CC’s undergo cyto-differentiation, proliferation, and expansion, and are important 
during early oocyte growth and development, maturation, ovulation, and fertilization [73, 171-
173].  Most infertility disorders are associated with decline in cumulus cell number, spindle 
abnormalities, and an altered cumulus oocyte association, leading to poor oocyte quality, as well 
as, poor reproductive outcomes [66, 129, 134, 145, 146, 174, 175].  Therefore, the presence of 
cumulus cells maintained in correct organization relative to the oocyte appears necessary for the 
protection and function of the oocyte.  Fatehi et al, have demonstrated that intact cumulus cells 
during in vitro fertilization protected bovine oocytes against oxidative stress and improved first 
cleavage [134].  In addition, incomplete denudation of oocytes prior to ICSI enhances embryo 
quality and blastocyst development [134].  Furthermore, the removal of cumulus cells before 
complete oocyte maturation showed a premature migration with partial exocytosis of cortical 
granules [176] as well as adversely affects early embryonic development [177, 178]. 
It has also been shown that apoptosis rates of human CC from morphologically abnormal 
oocytes were significantly higher than morphologically normal oocytes examined under 
transmission electron microscopy [73].  An increase in CC apoptosis has also been associated 
with immaturity of human oocytes, impaired fertilization, and suboptimal embryo development 
[73].  The mutual dependency of the oocyte and the CCs involves a complex and varied set of 
interactions, and the functionality of COC depends on the individual competence and 
cooperation of both the CC’s and the oocyte [73].  
In conclusion, the intact arrangement of viable, functional cumulus cells around the 
26 
 
oocyte is paramount to the quality and reproductive capacity of the oocyte.  Enhancement in the 
production or defective elimination of ROS and subsequent oxidative stress may be associated 
with infertility through a mechanism that involves the COC dysfunction and deterioration in 
oocyte quality.  The mechanisms through which the different ROS affect oocyte quality are 
through cumulus cell apoptosis, causing decreased number of cumulus cells, or decrease in 
cumulus cell viability. H2O2 like •OH, decreased the viability of cumulus cells; however at high 
concentrations decreased the number as well. HOCl, like ONOO-, stripped the cumulus cells 
from the oocyte as well as dissolved the zona pellucida.  The severity of the insult of ROS on 
cumulus-cumulus and cumulus-oocyte interaction depends mainly on the bioavailability of the 
antioxidant machinery provided by cumulus cells, and the scavenging ability of these 
antioxidants.  When increasing ROS concentration overwhelm the antioxidant machinery 
provided by the oocyte and /or cumulus cells, the mechanism of damage is most likely to be 
similar in both cumulus cells and oocyte. 
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CHAPTER 3 
THE IMPACT OF MYELOPEROXIDASE AND ACTIVATED MACROPHAGES ON 
METAPHASE II MOUSE OOCYTE QUALITY 
Abstract 
Myeloperoxidase (MPO), an abundant heme-containing enzyme present in neutrophils, 
monocytes, and macrophages, is produced in high levels during inflammation, and associated 
with poor reproductive outcomes.  MPO is known to generate hypochlorous acid (HOCl), a 
damaging reactive oxygen species (ROS) utilizing the hydrogen peroxide (H2O2) and chloride 
(Cl-).  Here we investigate the effect of the MPO system and activated macrophages on oocyte 
quality.  Mouse metaphase II oocytes with and without cumulus cells were divided into the 
following groups: 1) Incubation with a catalytic amount of MPO (40 nM) for different incubation 
periods in the presence of 100 mM Cl- with and without H2O2 and in the absence and presence of 
melatonin (100 µM), at 37°C (n=648/648); 2).  Co-cultured with activated mouse peritoneal 
macrophage cells (1.0 x 106 cells/ml) in the absence and presence of melatonin (200 µM), an 
MPO inhibitor and ROS scavenger, for different incubation periods in HTF media, at 37°C 
(n=200/200); 3).  Oocytes receiving no treatment and incubated for 4 hrs as controls (n=73/64).  
After treatment, oocytes were fixed, stained and scored based on the microtubule morphology 
(MT) and chromosomal alignment (CH).  Treatment with MPO and activated macrophages were 
all found to negatively affect oocyte quality in a time dependent fashion as compared to controls.  
In all cases the presence of cumulus cells offered no protection; however significant protection 
was offered by melatonin.  This work provides a direct link between MPO and decreased oocyte 
quality leading to poor reproductive outcomes.  Therefore, strategies to decrease the 
inflammation caused by MPO or its mediators may influence clinical outcomes in infertility 
patients.  
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Introduction 
There are many challenging questions and issues surrounding poor reproductive 
outcomes.  Many of these problems have come to the forefront of the medical field with greater 
expectations from medical science.  A substantial body of literature has proposed a link between 
oxidative stress and poor reproductive outcomes [2, 66, 120].  Oxidative stress, generated by 
reactive oxygen species (ROS) overproduction [120, 179] or myeloperoxidase (MPO) activity 
[56, 180], plays a central role in inflammation that causes these conditions [13, 181].  The 
deleterious actions of activated macrophages, the major source for ROS and MPO, are secondary 
to their ability to migrate to any site in the female genital tract and their cellular effects at the 
level of the oocyte [24-27, 182].  Under inflammatory conditions, activated macrophages are 
found in the cumulus cell mass within the cumulus oocyte complex (COC) [26, 182].  At sites of 
inflammation, the amount of MPO generated has been reported to reach a concentration of 1–2 
mM [28].  High levels of MPO have been found in the collected peritoneal fluid samples of 
patients with chronic genital diseases [35, 36], polycystic ovarian syndrome (PCOS) [37, 38], 
advanced stages of endometriosis [35, 39, 40], and pelvic inflammatory disease [35, 41, 42].  
Moreover, elevated MPO levels have also been found in the follicular fluid of women with 
chronic anovulation [43], which correlated to a decline in their fertility.  
Myeloperoxidase generates hypochlorous acid (HOCl) through MPO activity in the 
presence of chloride (Cl-) and hydrogen peroxide (H₂O₂) [19, 21].  Activated neutrophils 
generate around 150−425 μM HOCl/hr, while at areas of inflammation, the HOCl level can be 
reach as high as 5 mM [83, 183].  Under these conditions, HOCl not only destroys invading 
pathogens but can also cause damage through its capacity to react with other biomolecules, 
including aromatic chlorination, aldehyde generation, chloramine formation, and oxidation of 
thiols [179, 184].  Accumulation of HOCl can also mediate hemoproteins heme destruction and 
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subsequent free iron release and protein aggregation through a feedback mechanism involving 
MPO deterioration [56].  Both, HOCl and increased iron levels have been involved in several 
inflammatory conditions such as endometriosis [39, 84].  HOCl is a much more powerful oxidant 
in accelerating oocyte aging than other ROS through its ability to deteriorate the oocyte 
microtubule morphology (MT) and chromosomal alignment (CH), which are markers of oocyte 
quality [179].  Although MPO and HOCl are found in large amounts during inflammation 
contributing to poor reproductive outcomes, little is known about the exact mechanisms through 
which MPO affects oocyte quality.   
Recently, utilizing HPLC and amperometric integrated H2O2-selective electrode, our 
group demonstrated real time in vivo measurements of intracellular H2O2 and its ability to 
diffuse outside the oocyte to activate extracellular MPO generating HOCl [55].  The ability of 
this investigation to provide a precise measurement of in situ H2O2 was secondary to limiting 
reactivity with nearby biological processes and minimizing loss caused by diffusion, and 
demonstrated through the use of catalase that the measurements were that of H2O2 and not an 
unknown substance in our system [55].  Our results showed that the diffused H2O2 triggered 
MPO chlorinating activity, which in turn facilitated oocyte quality deterioration, which was 
shown to be preventable if oocytes were pre-treated with melatonin.  Melatonin, a known pineal 
hormone involved in the regulation of circadian rhythms [88, 89] has identified as a potent 
inhibitor of MPO chlorination activity and a potent scavenger of its final product, HOCl [16, 81, 
185].  The beneficial effect of melatonin on oocyte quality and fertilization has been previously 
described [76, 77, 185, 186].    
The current study demonstrates that MPO has a detrimental effect on oocyte quality 
through its chlorination activation, and defines the link between MPO (purified and naturally 
secreted from macrophages) and oocyte quality (MT and CH) deterioration; a mechanism that 
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can be prevented by using melatonin.  These results may help in designing treatment plans for 
assisted reproductive technologies for patients with inflammatory conditions.  
Materials and Methods 
Materials 
Hydrogen peroxide, melatonin, Human tubular fluid (HTF) media were purchased life 
technology, anti-α tubulin antibody, and Alexa Fluor® 488-AffiniPure Goat Anti-Mouse IgG 
(H+L) were purchased Jackson ImmunoResearch.  Propidium iodide (PI), 1% bovine serum 
albumin (BSA), 0.1% M glycine, 0.1% Triton X-100, sodium nitrite, and trypan blue, 
lipopolysaccharide (LPS) were purchased from Sigma Aldrich (St. Louis, MO, USA).  Normal 
goat serum 2% was purchased from Invitrogen and powdered milk, 0.2%, was obtained from 
grocery.  Peritoneal macrophage cells (non-stimulated, adherent, and non-dividing) derived from 
female C57BL/6 mice were obtained from Astarte Biologics, LLC (Bothell, WA) (1 x 106 /1ml), 
macrophage cell media and other supplements were also obtained from ScienCell Research 
Laboratories, Inc. (Carlsbad, CA).  The macrophage media (DMEM) with its supplemented 
materials and 10% Fetal Bovine Serum (FBS) were obtained from Science Cell Research 
Laboratories (Carlsbad, CA).  Other chemicals and reagents were of the highest purity grades 
available and obtained from Sigma Aldrich. 
Methods 
Myeloperoxidase Purification:   
Myeloperoxidase was purified initially from detergent extracts of human leukocytes by 
sequential lectin affinity and gel-filtration chromatography [187-189].  Trace levels of eosinophil 
peroxidase that may be contaminating were then removed by passage over a sulfopropyl 
Sephadex column [188].  Purity of isolated MPO was established by demonstrating a Reinheitzal 
(RZ) value of 0.85 (A430/A280), SDS–PAGE analysis with Coomassie blue staining, and gel 
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tetra- methylbenzidineperoxidase staining to the absence of eosinophil peroxidase activity. 
Enzyme concentration was determined spectrophotometrically utilizing extinction coefficients of 
89,000 M−1 cm−1/heme of MPO [190].  
Hydrogen peroxide solution:  
The H2O2 solutions were prepared fresh in phosphate buffer (PH 7.4), after which the 
concentration of the working solutions was determined spectrophotometrically (extinction 
coefficient of 43.6M -1 cm -1 at 240 nm) [191, 192].  During the preparation process, all the 
solutions were kept on ice to minimize decomposition. 
Melatonin solution:  
A stock solution of melatonin was dissolved in dimethylformamide (DMF) and diluted to 
the required concentration with phosphate buffer (pH = 7.4).  The final concentration of DMF in 
all melatonin solutions was less than 1% and did not interfere with MPO activity or have any 
effect on oocyte quality [2]. 
Oocyte preparation: 
Metaphase II mouse oocytes (with and without cumulus cells ) were obtained from a 
B6C3F1 mouse crossed with a B6D2F1 mouse in cryopreserved straws using ethylene glycol-
based slow freeze cryopreservation protocol (Embryotech Lab).  We chose to use frozen-thawed 
oocytes instead of fresh as both our group and others have performed many experiments on both 
and found that treatment of fresh and frozen oocytes with reactive oxygen species had yielded 
similar and reproducible results [3, 7, 44, 151, 152, 179].  Institutional Review Board approval 
was not required, as the oocytes were obtained from Embryotech.  Oocytes were transferred from 
straws to phosphate-buffered saline (Dulbeco’s PBS) and washed to remove excess 
cryoprotectant for 5 minutes.  Oocytes were then transferred to HTF media and incubated at 
37ºC and 5% CO2 for 60 minutes to allow repolymerization of spindles.  The oocytes were then 
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screened for the presence of polar bodies confirming their metaphase II stage [56].  Ten to 
twenty oocytes from each group were discarded as they were found to be immature or displayed 
disrupted zona pellucida (ZP). 
Purified myeloperoxidase treatment on oocytes (with and without cumulus cells) 
Using the same processes for oocytes handling as mentioned in the previous section, 
metaphase II mouse oocytes with (n = 648) and without cumulus cells (n = 648) were divided 
into the following groups, which were performed in triplicate.  
Group 1: oocyte incubated with fixed concentration of MPO (40 nM) at different 
incubation period ( 3, 6, 12, and 24 hrs);  group 2: oocytes incubated with fixed concentration of 
MPO (40 nM) + 20 µM H2O2 at different incubation period ( 3, 6, 12, and 24 hrs); group 3: 
oocytes incubated with fixed concentration of MPO (40 nM) at different incubation period (3, 6, 
12, and 24 hrs) preincubated with melatonin (100 µM); group 4:  oocytes incubated with fixed 
concentration of MPO (40 nM) + H2O2  (20 µM) at different incubation period (3, 6, 12, and 24 
hrs) on oocytes preincubated with melatonin (100 µM); group 5: Untreated oocytes were used as 
a control; and group 6: oocytes with melatonin (100 µM) alone for 24 hr incubation period.  All 
oocytes were fixed at the time points (3, 6, 12, and 24 hrs) and evaluated for alteration of the 
following: MT structure and CH alignment.  All experiments were carried out in HTF media 
containing 100 mM Cl- which is similar to the physiological oviduct Cl- concentration [193].  All 
cell transfers were performed by using 200-mm micropipette tips (ORIGIO, Cooper Surgical).  
Macrophage cells co-cultured with oocytes (with and without cumulus cells) 
We followed the protocol of macrophage cell co-culture as described by Honda et al 
(1994) [29] with some modifications.  The 1 ml vials containing macrophage cells (1.0 x 106 
cells/vial) were thawed at 37ºC then centrifuged at 1800 rpm at 4ºC for 5 min then the 
cryopreservative solution was removed and replaced with the macrophage media, mixed, and 1 
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µl of the media containing macrophage cells was used to test the cell viability using Trypan blue 
dye exclusion assay.  Cells were recounted before utilization and were placed into 30 mm dishes 
(Falcon).  The macrophage concentration per dish was chosen secondary to previous data which 
showed a significant reduction in fertilization rate in co-culture group as compared to control 
[29].  Macrophage cells were stimulated with lipopolysaccharide (LPS) (10 ng/ml) for maximal 
MPO secretion [194, 195].  Cells were allowed to rest for 16 hr at 5% CO2, 37ºC to allow the 
cells to adhere to the base of culture dishes. The following day, the macrophage media was 
removed, washed with PBS twice, and then with HTF twice to remove the unadherent cells and 
replaced with HTF media.  Cells were then reincubated at 5% CO2, 37ºC to be ready for co-
cultured with the oocytes.  
In the triplicate experiment, the oocytes (with n = 200 and without cumulus cells n = 200, 
total) were divided into the following groups: group 1: oocytes with and without cumulus cells 
incubated with stimulated macrophage cells for 1, 2, 3, and 4 hrs; group 2: oocytes with and 
without cumulus cells incubated with stimulated macrophage cells preincubated with melatonin 
(200 μM) for 1, 2, 3, and 4 hrs; group 3: oocytes with and without cumulus cells incubated with 
100 μM melatonin alone for 4 hrs; group 4: control oocytes receiving no treatment and incubated 
for 4 hrs. All groups were incubated in HTF for 4 hrs, 37ºC, 5% CO2.  We chose 4 hrs of 
incubation as previous studies stated that 4-6 hrs is the time for optimal fertilization [196, 197].  
The doses of melatonin, and HOCl were selected on the basis of our preliminary results and our 
previous studies [16, 185].  All oocytes were fixed at the time points (1, 2, 3, and 4 hrs) and 
evaluated for alteration of the following: MT structure and CH alignment.  
Immunofluorescence staining and fluorescence microscopy 
Oocytes were fixed in a solution prepared from 2% formaldehyde and 0.2 % Triton X-
100 for 30 minutes and then treated with blocking solution (PBS, 0.2% Powdered Milk, 2% 
34 
 
Normal Goat Serum, 1% BSA, 0.1 M Glycine and 0.1% Triton X-100) for 1 hr followed by PBS 
washing for 3 minutes.  The oocytes were then subjected to indirect immunostaining using 
mouse primary anti-α tubulin antibody against the MT (1:100, overnight) and secondary Alexa 
Fluor® 488-AffiniPure Goat Anti-Mouse IgG (H+L) (1:50, 1 h).  The chromosomes were 
stained using PI for 10 min. Stained oocytes were loaded into anti-fade agent on slides with two 
etched rings. Images were obtained utilizing both immunofluorescence and confocal microscopy.  
Confocal microscopy, assessment of microtubules and chromosomal alignment 
Confocal microscopy, assessment of microtubules morphology and chromosomal 
alignment slides were examined with the Zeiss LSM 510 META NLO (Zeiss LSM 510 META) 
microscope using PI (red) and Alexa Fluor® 488 (green) fluorescent filters with excitation and 
emission wavelengths of 470 and 525 nm, 496 and 519 nm, respectively.  Oocytes were localized 
using a 10x magnification lens and spindle alterations assessed using 100 x oil immersion lens. 
The MT was stained fluorescent green, which was distinct from the fluorescent red staining of 
chromosomes.  The alterations in the MT and CH were compared with controls and scored by 
three different observers blinded to treatment groups based on a previously published scoring 
system using comprehensive evaluation of the individual optical sections and the 3-D 
reconstructed images (Figure 2) [185, 198].  Scores of 1-4 were assigned for both MT and CH 
alterations, with scores 1 and 2 combined for good outcomes meaning microtubules were 
organized in a barrel-shaped with slightly pointed poles formed by organized microtubules 
crosswise from one pole to and chromosomes were normally arranged in a compact metaphase 
plate at the equator of the spindle.  Scores of 3 and 4 signified poor outcomes and consisted of 
spindle length reduction, disorganization and/or complete spindle absence, and chromosome 
dispersion or aberrant condensation appearance.  
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Statistical analysis:  
Statistical analyses were performed using SPSS version 21.0 (SPSS Inc., Chicago, IL, 
USA).  One-way ANOVA analyses were performed to compare the percentage of oocytes with 
poor outcomes (scores 3 and 4) for MT and CH between controls with various time intervals and 
each treatment group applied to cumulus and non-cumulus oocytes.  The same ANOVA 
procedures were also performed to investigate the effects of different treatments on cumulus and 
non-cumulus oocytes at different time intervals.  Pair wise comparisons made using Tukey’s post 
hoc test following significant ANOVA tests, which defined as P<0.05.  Independent t tests were 
conducted to compare the cumulus and non-cumulus oocytes for each treatment and time interval 
combination. 
Results 
Effect of purified MPO/melatonin on MT and CH of metaphase II oocytes without and with 
cumulus cells 
To test whether MPO activation through the extra-oocyte diffusion of H2O2 could 
deteriorate the mouse metaphase II oocyte quality, we investigated the time dependent effect of 
MPO, in the absence and presence of melatonin, a potent MPO inhibitor, on oocyte MT and CH 
in the absence and presence of cumulus cells.  Incubation of the oocytes with MPO alone (40 
nM) showed significant deterioration in oocytes quality in a time depended manner as judged by 
alterations in the MT and CH in the treatment groups and cumulus cells show no protection   
(Figure 9A & B-upper Panels).   
Whereas the presence of 100 µM melatonin showed significant protective effect on MT 
and CH when incubated with MPO for shorter time (3 hrs) and this protection was lost by longer 
time of incubation (Figure 9A & B-lower Panels).  Pre-supplementing the oocyte medium with 
more melatonin concentrations (400 µM), showed more protection in the oocyte quality up to 6 
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hrs of incubation with MPO (data not shown).  These results concluded that preservation of 
normal MT and CH under MPO activity can be achieved by using the antioxidant and MPO 
inhibitor, melatonin.  
 
Figure 9: Images of oocytes microtubule morphology (MT) and chromosomal alignment (CH) obtained using 
Confocal Zeiss LSM 510 META NLO microscope.  A) Oocytes without cumulus cells showed:  -Upper Panel: 
Detrimental time dependent effect of myeloperoxidase (MPO) (40 nM) on MT and CH.  -Lower Panel: Melatonin 
(MLT) supplementation (100 µM) showed normal MT and CH in the presence MPO at 3 hrs of incubation similar to 
controls and alterations in MT and CH by increasing the incubation time.  B) Oocytes with cumulus cells showed 
similar observations that have been seen in A for MPO effect in the absence and presence of MLT. Collectively, 
cumulus cells failed to offer significant protection against MPO catalytic activity. Scale bars: 1 pixel, 5 mm for 
images A and 1 pixel, 3 mm for images B. Results depict observations made after three experiments. 
 
For comparison, the effect of MPO, in the absence and presence of melatonin, on MT and 
CH were quantitated based on our well established 1-4 scoring system (see method section for 
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more details) and the percentages of poor scores were blotted as a function of time (Figures 10 
and 11). 
 
Figure 10: The effect of MPO/HOCl system on oocytes quality in the presence and absence of cumulus cells.   
Both panels show triplicate experiments of the percentage of oocytes with cumulus (n=648) (green bars) versus 
those without (n=648) (gray bars) with poor microtubule morphology (MT) scores observed in the untreated oocytes 
compared to oocytes treated with a fixed catalytic MPO concentration (40 nM) without addition of H2O2 (20 µM) 
(upper panel) and after addition of H2O2 (20 µM) (lower panel).  All oocytes were incubated to different times of 
incubation (3, 6, 12 and 24 hrs) followed by indirect immunofluorescence staining method to observe MT and CH. 
Human tubulin fluid (HTF) media contains similar chloride (Cl-) concentration (~100 mM) to the oviduct fluid. 
There is a time dependent effect of MPO activity on oocytes quality in the presence and absence of cumulus cells (p 
< 0.05).  Cumulus cells fail to protect MT against damage from MPO activity (p > 0.05).  Similar results were 
observed for the chromosomes alignment (CH). One-way ANOVA and independent t-test using SPSS 22.0 used to 
analyzed the results as following: (a) P < 0.05   non-cumulus oocytes as compared to control. (b) P < 0.05 cumulus 
oocytes as compared to control. (c) P < 0.05   between cumulus and non-cumulus oocytes. H2O2 addition on the 
oocytes in the lower panel showed no significant difference compared to oocytes in the upper panel. The standard 
error for each point was estimated to be less than 10%. 
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Figure 11: The protective effect of melatonin against MPO/HOCl system on oocytes quality in the presence 
and absence of cumulus cells. Both panels show triplicate experiments of the percentage of oocytes with cumulus 
(n=648) (green bars) versus those without (n=648) (gray bars) with poor microtubule morphology (MT) scores 
observed in the untreated oocytes compared to oocytes treated with a fixed catalytic MPO concentration (40 nM) 
without addition of H2O2 (20 µM) (upper panel) and after addition of H2O2 (20 µM) (lower panel) after pre-
supplement the oocytes media with melatonin (100 µM).  All oocytes were incubated to different times of 
incubation (3, 6, 12 and 24 hrs) followed by indirect immunofluorescence staining method to observe MT and CH. 
Human tubulin fluid (HTF) media contains similar chloride (Cl-) concentration (~100 mM) to the oviduct fluid. 
Melatonin showed a significant protection against MPO activity at 3 hrs incubation (p < 0.05) as it works as direct 
HOCl scavenger and MPO inhibitor. The poor scores in MT showed by increasing the time of incubation caused as 
melatonin have been consumed. Cumulus cells fail to protect MT against damage from MPO activity (p > 0.05).  
H2O2 addition on the oocytes in the lower panel showed no significant difference compared to oocytes in the upper 
panel. Similar results were observed for the chromosomes alignment (CH). One-way ANOVA and independent t-
test using SPSS 22.0 used to analyzed the results as following: (a) P < 0.05   non-cumulus oocytes as compared to 
control. (b) P < 0.05 cumulus oocytes as compared to control. (c) P < 0.05   between cumulus and non-cumulus 
oocytes. The standard error for each point was estimated to be less than 10%.  
Figure 10 upper Panel showed the time dependent increase in the percentage of poor 
scores for MT and CH for oocyte with and without cumulus cells incubated with MPO.  In the 
absence of cumulus cells, 3 hrs incubation with MPO showed 48% poor scoring and stayed 
almost the same at 6 hrs incubation and increased to 70%, and 100% at 12 and 24 hrs 
respectively, compared to control group 18.6%.  Almost similar results were observed for 
oocytes MT and CH with cumulus cells incubated with the same amount of MPO for the same 
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incubation periods (36.6%, 38.7%, 70%, and 82% poor scores,  respectively, compared to control 
groups 9.0%).  
Figure 11 showed the protective effect of melatonin on oocyte quality against MPO 
treatment.  Oocytes without cumulus cells incubated with MPO/melatonin showed a significant 
decrease in the percentages of poor scores MT and CH at 3 hr (7%) of incubation compared to 
longer incubation periods 6, 12 and 24 hrs (57%, 70%, and 100%, respectively) (p<0.001) 
(Figure 11 upper panel/gray bars).  Whereas, the poor scores for cumulus oocytes incubated for 
the 3, 6, 12, and 24 hrs with melatonin/MPO were approximately 1.3%, 23.3%, 50%, and 70%, 
respectively as compared with the control group score average of 1.0% (Figure 11 upper 
Panel/green bars).  In control experiments, oocytes incubated with melatonin alone for 24 hr 
showed poor scores of ~10.0% similar to untreated oocytes. Cumulus cells showed a sign of 
protection against MPO in the presence of melatonin at 6 hrs of incubation (p<0.05).   
To determine whether MPO activation is the major cause for oocyte quality deterioration, 
we repeated the same experiments in the presence of exogenously added H2O2 (20 µM) to the 
oocytes media immediately after MPO addition and incubated the oocytes for the same 
incubation times (3, 6, 12 and 24 hrs) in the absence and presence of 100 µM melatonin (Figures 
10 and 11-lower Panels).  Our results showed that in the absence of cumulus cells, the poor 
scores for MT and CH for 3, 6, 12 and 24 hrs of incubation periods with MPO/H2O2 alone were 
60%, 63.3%, 100% and 100% respectively (Figure 10-lower Panel/gray bars).  In the presence of 
cumulus cells, the percentage of poor scores for 3, 6, 12, and 24 hrs of incubation periods with 
MPO/H2O2 alone were 50%, 53%, 60%, and 100% respectively (Figure 10-lower Panel/green 
bars).  Results in this section mirrored those of the above experiment (Figure 10, upper Panel) in 
which H2O2 supplementation had no additional effect on oocyte quality (p>0.05), and again 
cumulus cells did not appear to provide protection to the oocyte (p>0.05).  The poor scores of 
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non-cumulus oocytes (for MT and CH) incubated with melatonin/MPO/H2O2 for 3, 6, 12, and 24 
h incubation were 20%, 63.3%, 73.3%, and 100% respectively (Figure 11 lower Panel/gray 
bars).  Under these circumstances, melatonin also showed a protection at 3 hrs of incubation; but 
not in the other incubation periods.  In the presence of cumulus cells, the poor scores for oocytes 
MT and CH incubated with the same treatments for the same incubation periods were 25%, 60%, 
60%, and 100% respectively (Figure 11 lower Panel/green bars).  Results in this section mirrored 
results without addition of H2O2, in that the presence of melatonin protected against MPO with 
H2O2 in the 3 hrs group (p<0.001); but not in the 6, 12, or 24 hrs groups (p>0.05).  Cumulus cells 
did not showed a protective effect after 6 hrs of incubation in the presence of melatonin and 
MPO with H2O2 (p>0.05).  Collectively, inhibiting MPO activity by using melatonin preserve 
the quality of the oocytes, thus MPO activity is the major cause of poor oocyte quality. 
Effect of stimulated macrophages on MT and CH of metaphase II oocytes without and with 
cumulus cells 
Since purified MPO activity was responsible for oocyte quality deterioration, then we test 
whether the exposure to stimulated macrophages could mediate deterioration of the oocytes 
quality through a mechanism that involves the MPO catalysis.  To test this hypothesis, we co-
cultured the oocytes with stimulated macrophages as function of time, in the presence and 
absence of melatonin (200 µM).  
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Figure 12:  The direct effect of stimulated macrophages on oocyte quality, microtubule morphology (MT) and 
chromosomal alignment (CH), in the absence (gray bars) and presence (green bars) of cumulus cells. There 
was a significant time dependent effect of stimulated macrophages on MT and CH (p<0.05). Cumulus cells did not 
offer significant protection against macrophages activity (p>0.05). The experiments were conducted with three 
replications and the error bars represent the standard error of the mean.  
As showed in Figure. 12, in the absence of cumulus cells, the poor scores for the oocytes 
incubated with stimulated macrophage for 1, 2, 3 and 4 hrs were approximately 35.5%, 54.4%, 
78.5% and 100% for MT and CH (Figure 12).  In the presence of cumulus cells, the average poor 
scores for the oocytes incubated with stimulated macrophage cells for 1, 2, 3 and 4 hrs was 
approximately 43.3%, 36.1%, 65.7% and 93.3% for MT and CH (Figure 12).  Overall, as showed 
in Figure. 10, increasing the incubation time increased significantly the poor scores for MT and 
CH (p<0.05).  
Figure 13 demonstrated the power of melatonin to inhibit the activity of naturally MPO 
secreted form stimulated macrophages.  The poor scores for noncumulus oocytes MT and CH 
incubated with melatonin/stimulated macrophage cells for 1, 2, 3 and 4 hrs were approximately 
20.5%, 63.8%, 93.3% and 100%  (Figure 13).  While, in the  presence of  cumulus cells, the poor  
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Figure 13:  The protective effect of melatonin (MLT) against stimulated macrophages activity on oocytes 
quality (MT and CH) in the absence (gray bars) and presence (green bars) of cumulus cells.  The presence of 
melatonin (200 µM) showed significant protection for MT and CH at 1 hr incubation (p<0.05). In general, cumulus 
cells did not offer significant protection against macrophages activity (p>0.05). The experiments were conducted 
with three replications and the error bars represent the standard error of the mean. 
scores for MT and CH for 1, 2, 3 and 4 hrs were approximately 8.9%, 58.3%, 86.6% and 93% 
(Figure 13).  Overall, melatonin showed a significant protection of MT and CH quality at 1 hr of 
incubation with macrophage cells (p<0.05) compared to longer time periods.  The control group 
had poor scores for approximately 20% of noncumulus and 16.6% for cumulus oocytes (p>0.05).  
Cumulus cells showed a non-significant protective effect against MPO secreted from stimulated 
macrophages in the presence and absence of melatonin at 2, 3, and 4 hrs of incubation (p>0.05).  
Collectively, the major cause for oocytes quality deterioration is the activation of macrophages 
as well as MPO that can be successfully inhibited by using melatonin. 
Discussion 
Recent studies have shown that intra-oocyte H2O2 concentration is relatively high and 
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diffuses to the extracellular environment of the oocyte [55, 199].  Our current study confirms and 
extends these results and indicates that the diffused H2O2 deteriorates oocyte quality through 
MPO activation independent of cumulus cells and exogenously added H2O2, and could be 
prevented by treatment with melatonin, a potent inhibitor of MPO chlorinating activity [16, 81, 
185].  Similarly, stimulated macrophages were also found to deteriorate oocyte quality 
independent of cumulus cells presence in a time dependent fashion, and could be prevented by 
melatonin.  Macrophages are one of the principal defense mechanisms of innate immunity [200, 
201]  as a source of MPO and other toxic molecules used in controlled environments to degrade 
invading pathogens [19, 20].  Although, the association between macrophages and infertility has 
been repeatedly reported [6, 12, 202], the current work is the first to mechanistically link the 
MPO activity with the deterioration in the oocyte quality which adversely influences infertility.  
All the indications point to diffused intra-oocyte H2O2 being sufficient to trigger the 
MPO chlorinating activity (generation of HOCl), which was responsible for the loss of oocyte 
quality.  Hydrogen peroxide is a naturally occurring molecule within the oocyte and high a 
portion appears to diffuse outside the oocyte [55].  Hydrogen peroxide is an uncharged stable 
molecule, and permits through biological membranes in a fashion similar to water [203, 204] via 
limited diffusion and transport through specialized proteins known as aquaporins [205].  MPO 
activated through intraoocyte diffused H2O2, was found to negatively affect oocyte quality in 
time dependent manner in a similar trend to that recently observed when oocytes treated with 
increasing concentration of exogenous HOCl (Figure 2C) (Shaeib et al., in press. 2015).  
Treatment with HOCl disturbs the antioxidant capacity of cumulus cells by decreasing the 
number and/or viability of these protective cells (Figure 2C) (Shaeib et al., in press. 2015). 
Indeed, MPO treatment was found to mediate cumulus oocyte damage to almost the same extent 
as that in the absence of cumulus cells.  HOCl may mediate oxidative damage and/or oocyte 
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fragmentation through its ability to undergo numerous reactions with biomolecules, including 
aromatic chlorination, chloramine formation, aldehyde generation, and oxidation of thiols [179, 
184].  Preservation of oocyte quality by melatonin provides further evidence for the involvement 
of MPO activation in causing oocyte quality deterioration [16, 185].  The ability of MPO to 
utilize melatonin as a one electron substrate to produce less antioxidant substances, such as N1-
acetyl-N2-formyl-5-methoxynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), 
limits the duration of the oocyte protection by the amount of the melatonin provided [97, 98].  
Previously, we have shown that pre-incubation of oocytes with increasing concentrations of 
melatonin prior to HOCl treatment significantly prevented HOCl-mediated deterioration of 
oocyte quality [185].  It has been further demonstrated that, under specific condition, melatonin 
treatment could significantly improve fertilization and pregnancy rates [90, 123].  This work 
provides a direct link between MPO and deterioration of oocyte quality leading to poor 
reproductive outcomes.   
Several inflammatory diseases such as endometriosis, polycystic ovarian syndrome, 
diabetes, are not only associated with increased ROS production but also increased MPO levels 
[35, 37-40, 206, 207].  In these disorders, elevated MPO levels have also been linked directly 
or indirectly with decline in fertility [2, 208].  We have previously showed that oocytes 
obtained from women with endometriosis display granulosa cells apoptosis, positive for 
nitrotyrosine, premature cortical granule exocytosis in oocytes, disrupted microtubular 
morphology, and disrupted chromosomal alignment [209].  The deterioration of these oocyte 
quality parameters is not only caused by ROS but may also occur through MPO catalysis 
consistent with our current results [55, 56, 185].  Elevated MPO activity shifts the environment 
from one of host defense to one capable of host damage directly through the generation of ROS 
or indirectly through hemoprotein heme destruction and subsequent free iron release [56].  Free 
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iron (most commonly Fe2+) through H2O2 driven Fenton reaction yields •OH, which propagates 
deterioration in oocyte quality contributing to the development of infertility [14, 15, 210].  
MPO can also consume NO as a physiological one electron (1e-) substrate [211].  Direct 
quantitative NO measurements utilizing NO-selective electrodes revealed that there is a 
significant amount of NO inside the oocyte [212].  NO deficiency has been shown to 
deteriorate oocyte quality and accelerate oocyte aging [7, 44].  Thus, MPO may damage the 
oocytes through multiple pathways: generation of oxidants such as HOCl and •OH, serving as a 
source of free iron, and depleting NO.    
MPO is produced in high levels during inflammation throughout of the female 
reproductive tract from stimulated inflammatory cells such as neutrophils, monocytes, and 
macrophages [40, 120, 213, 214].  The distribution of macrophages in the ovary during different 
stages of oocyte development, as well as their presence in peri‐ovulatory human follicular fluid, 
suggest that macrophages play important roles in folliculogenesis and tissue restructuring at 
ovulation [25, 26].  Indeed, during oocyte development in mice, rats, and humans, macrophages 
are recruited into the cellular layers of the follicle causing their numbers to be greatest just prior 
to ovulation [25, 182].  Activation of these macrophages or recruitment of other immune cells in 
the presence of inflammation for any reason can therefore contribute to deterioration in oocyte 
quality.  Activated macrophages may mediate oocyte quality damage not only through triggering 
of MPO chlorinating activity, but also through reactive oxygen species and cytokine cascades.  
Previously, we have shown that ROS such as O2•-, H2O2, •OH, and ONOO-, as well as,  IL-6, 
generated in the process of oxidative stress, not only regulates the inflammatory setting and 
contributions in keeping of chronic inflammatory state but also directly or indirectly affects the 
metaphase-II oocyte spindle and significantly contributes to infertility [2, 3, 56, 179].  Similarly, 
treatment with melatonin (MPO inhibitor and ROS scavenger) highlights the culpability of 
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macrophages in affecting oocyte quality.  
Parallel to increased expression of MPO in inflammation, research has demonstrated 
elevations in macrophage concentration and activity in conditions such as polycystic ovarian 
syndrome and endometriosis related infertility [26, 215-218].  Non-activated peritoneal 
macrophages when co-cultured with the oocyte post fertilization leads to higher rates of 
development in in-vitro embryos when compared to the control group [29].  In support of the 
variable role of macrophages based on activation status, an association has been demonstrated 
between endometriosis and increased numbers of macrophages; however concluded based on 
colorimetric assay of MPO activity that impaired function or abnormal activation, and not 
macrophages population size is important for endometriotic tissue proliferation [208].  Similarly, 
high concentrations of inflammatory cytokines (TNF and IL-1) secreted from activated 
macrophages have been shown to cause deleterious effects on pre-implantation embryos [219].  
Therefore, increased macrophage activation in the follicular fluid may cause a disruption in 
folliculogenesis and the deterioration in oocyte quality observed in pathologic conditions causing 
infertility [6, 24, 220, 221].  As shown in in vitro studies, oxidative states generated upon 
activating macrophages may also compromise oocyte quality by affecting the meiotic spindle [2, 
3, 55, 56, 179, 185, 198].  Thus, irrespective of whether purified MPO or activated macrophages 
are utilized, this works provides an initial mechanistic link between MPO activity and 
deterioration in oocyte quality.   
In conclusion, our current work showed for the first time the link between stimulated- 
macrophages, a major source of MPO, and oocyte quality deterioration, highlighting the 
implications of these cells in infertility caused by inflammatory conditions.  Melatonin has 
potential therapeutic effects in preserving oocyte quality, thus improving reproductive outcomes 
in patients with chronic inflammation.   
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CHAPTER 5 
MELATONIN PREVENTS MYELOPEROXIDASE HEME DESTRUCTION AND THE 
GENERATION OF FREE IRON MEDIATED BY SELF-GENERATED 
HYPOCHLOROUS ACID 
(This chapter contains previously published material. See Appendix B). 
Abstract 
Myeloperoxidase (MPO) generated hypochlorous acid (HOCl) formed during catalysis is 
able to destroy the MPO heme moiety through a feedback mechanism, resulting in accumulation 
of free iron.  Here we show that the presence of melatonin (MLT) can prevent HOCl-mediated 
MPO heme destruction using a combination of UV-visible photometry, hydrogen peroxide 
(H2O2)-specific electrode, and ferrozine assay techniques.  High performance liquid 
chromatography (HPLC) analysis showed that MPO heme protection was at the expense of MLT 
oxidation.  The full protection of the MPO heme requires the presence of a 1:2 MLT to H2O2 
ratio.  Melatonin prevents HOCl–mediated MPO heme destruction through multiple pathways.  
These include by competing with chloride, the natural co-substrate; switching the MPO activity 
from a two electron oxidation to a one electron pathway causing the buildup of the inactive 
Compound II, and its subsequent decay to MPO-Fe(III) instead of generating HOCl; binding to 
MPO above the heme iron, thereby preventing the access of H2O2 to the catalytic site of the 
enzyme; and direct scavenging of HOCl.  Collectively, in addition to acting as an antioxidant and 
MPO inhibitor, MLT can exert its protective effect by preventing the release of free iron 
mediated by self-generated HOCl.  Our work may establish a direct mechanistic link by which 
MLT exerts its antioxidant protective effect in chronic inflammatory diseases with MPO 
elevation. 
Introduction 
Melatonin (MLT) is naturally synthesized from the amino acid tryptophan in the pineal 
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gland, but also by other non-endocrine organs (e.g., cerebellum, cerebral cortex, retina, skin, 
ovary, liver, pancreas, kidneys, and immune competent cells), and acts through 2 G-protein 
coupled receptors, MT1 and MT2 [91, 222-224].  In humans, like most vertebrates, MLT 
operates as a modulator of circadian rhythms, and displays an oscillatory pattern through its 
unique ability to function as a signal, which organisms use to synchronize their circadian 
system [91, 225].  Through its ability to scavenge a wide range of reactive oxygen species 
(ROS), multiple studies have shown distinct antioxidant and anti-inflammatory effects when 
MLT is administered either exogenously in vivo or when added to cultured cells via regulation 
of cellular pathways [51, 91, 112-114, 226].  The effects and action mechanisms of MLT 
belong to or take part in many different cell types including inflammatory cells such as 
monocytes–macrophages, neutrophils, eosinophils, basophils, mast cells, and natural killer 
cells [114, 115].  Therefore, various doses of synthetic MLT supplements have been used to 
treat a variety of medical scenarios such in which inflammation plays a role such as weakened 
immune system due to stress, oxidative hemolysis of red blood cells, and cancer progression 
[116, 117].  Recently, we have shown that MLT is a potent inhibitor of the inflammatory 
enzymes myeloperoxidase (MPO) and other related peroxidases (e.g. eosinophil peroxidase) 
[81, 104, 227].  
Myeloperoxidase is a heme protein, present in the neutrophils, which utilizes chloride 
(Cl-) in the presence of H2O2 to generate HOCl [141, 228].  This process occurs through H2O2 
reduction that leads to the formation of MPO Compound I (ferryl porphyrin  cation radical, 
Fe(IV)=O(+•)), which oxidizes Cl- to HOCl [229].  Myeloperoxidase compound I is also 
capable of oxidizing various organic and inorganic substrates by two successive 1e− transfers 
generating compound II (MPO-Fe(IV)=O) and MPO-Fe(III), respectively.  The rate limiting 
step in a typical peroxidase cycle is the reduction of compound II to MPO-Fe(III).  
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Furthermore, physiological reductants such as superoxide, nitric oxide, MLT, and ascorbic 
acid are known to accelerate this process [81, 230-234].  Hypochlorous acid is a potent oxidant 
that is capable, under normal circumstances, of functioning as a powerful antimicrobial agent 
[141, 228].  However, under a number of pathological conditions such as inflammatory 
diseases, in which ROS production can become excessive, HOCl is capable of mediating 
tissue damage [141, 235].  Interestingly, many inflammatory disorders such as ovarian cancer 
and atherosclerosis, in which MPO/HOCl has been known to be elevated, are also associated 
with significant free iron accumulation [15, 84, 236, 237].  Recently, we have highlighted the 
potential link between elevated HOCl and hemoprotein heme destruction, and subsequent 
generation of free iron [57, 229, 238].  Detailed mechanistic insight into how exogenously 
added or self-generated HOCl mediates the MPO heme moiety has recently been elucidated 
[57, 70].  Therefore, factors that influence rates of HOCl removal are of growing interest [156, 
185, 228, 239-242].  Here, we examine the ability of MLT to prevent HOCl-mediated heme 
destruction and subsequent iron release.  These findings may have therapeutic repercussions as 
they elucidate the mechanism behind the rationale for addition studies on MLT 
supplementation for patients with chronic inflammatory conditions in which MPO is elevated.  
Additionally, this work may open the door for the development of other treatment 
interventions in this patient population.  
Materials and Methods 
Materials 
All the materials used were of highest-grade purity and used without further purification. 
Sodium hypochlorite (NaOCl), H2O2, ammonium acetate (CH3COONH3), ferrozine, MLT, 
ascorbic acid, and dimethylformamide, were obtained from Sigma Aldrich (St. Louis, MO, 
USA).  
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General Procedures  
MPO purification 
MPO was initially purified from detergent extracts of human leukocytes by sequential 
lectin affinity and gel filtration chromatography [58, 187, 188].  Trace levels of contaminating 
eosinophil peroxidase (EPO) were then removed by passage over a sulfopropyl Sephadex 
column [188].  Purity of isolated MPO was established by demonstrating a Reinheitszahl (RZ) 
value of >0.85 (A430/A280), SDS−PAGE analysis with Coomassie Blue staining, and gel 
tetramethylbenzidine peroxidase staining to confirm no contaminating EPO activity.  Enzyme 
concentration was determined spectrophotometrically utilizing extinction coefficients of 89,000 
M-1 cm-1/heme of MPO [190].  
H2O2-selective electrode measurements 
Hydrogen peroxide measurements were carried out using an H2O2-selective electrode 
(Apollo 4000 free radical analyzer; World Precision Instruments, Sarasota, FL, USA). 
Experiments were performed at 25°C by immersing the electrode in 3 ml of 0.2 M sodium 
phosphate buffer, pH 7.0.  Experiments were carried out under two different conditions: 
sequential additions of 10 M H2O2 to a continuously stirred buffer solution supplemented with 
40 nM MPO and 100 mM Cl- in the absence and presence of 200 µM MLT during which the 
change of H2O2 concentration was continuously monitored. 
Absorbance measurements 
The absorbance spectra were recorded using a Cary 100 Bio UV–visible photometer, at 
25 C, pH 7.0.  Experiments were performed in 1 ml phosphate buffer solution supplemented with 
MPO (1.0-1.5 μM), 100 mM Cl-, and incremental addition of 180 μM of H2O2 (20 μM; 2 μl) in 
the absence and presence of increasing MLT concentrations (0-200 μM).  After each H2O2 
addition, the reaction mixture was left 10 min for reaction completion and absorbance spectra 
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were then recorded from 300 to 700 nm.     
Free iron analysis 
Free iron release was measured colorimetrically using ferrozine, following a slight 
modification of a published method [243].  To 100 μl of the sample (MPO–HOCl reaction 
mixture) 100 μl of ascorbic acid (100 mM) was added.  After 5 min of incubation at room 
temperature, 50 μl of ammonium acetate (16%) and the same volume of ferrozine (16 mM) were 
added to the mixture and mixed well.  Subsequently, the reaction mixture was incubated for 
5 min at room temperature and the absorbance was measured at 562 nm.  A standard curve 
prepared using ammonium Fe(III) sulfate was used for the calculation of free iron concentration.  
Final concentrations of the additives were as follows: ascorbic acid, 33.33 μM; ammonium 
acetate, 5.3%; and ferrozine, 5.3 μM. 
High Performance Liquid Chromatography (HPLC) 
HPLC analyses were performed using a Shimadzu HPLC system equipped with an SCL-
10A controller, LC-10 AD binary solvent delivery pumps, SIL-10 AD autosampler, SPD-M10 A 
diode array detector, and an RF-10 A XL fluorescence detector.  An Alltech 5 um particle size 
column was used with a 4.6 x 150 mm reverse phase octadecylsilica (C18).  To monitor the 
chromatogram, the RF fluorescence detector was set at 321 nm for excitation and 465 nm for 
emission and the SPD diode array detector was set at 400 nm. HPLC grade solvents were 
prepared as follows: solvent A, 0.1% TFA in water and solvent B, 0.1% TFA in 80% 
acetonitrile.  Solvent gradients were set as follows: 0-10 min 55-65% B, 10-14 min 65-90% B, 
followed by reducing solvent B composition to 55% within 14-24 min.  The column elution was 
carried out at flow rate of 0.8 ml/min with a linear gradient of solvents.  After treatment of MLT 
with MPO in presence of H2O2 for 24 hr, the reaction mixture was filtered through an Amicon 
Ultra-15 centrifugal filter unit with Ultracel-10 membrane (from Millipore) 3-kDa cut-off by 
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centrifuging at 14,000 rcf rate for 30 min at 4°C; then 50 μl of filtered sample was injected for 
analysis.  At the end of the run the system was equilibrated with 45% solvent A; each sample 
was analyzed in triplicate.  
N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) synthesis 
The AFMK was synthesized following the method of Tan et al. [244] with slight 
modification.  Briefly, 5 mg MLT were dissolved in 100 µL methanol and the reaction mixture 
was mixed with 500 µL H2O2 (30%).  The formation of AFMK was followed by the increase in 
absorbance at 340 nm. AFMK was isolated and confirmed by HPLC analyses.   
Solution preparation 
HOCl preparation 
HOCl was prepared as previously described with some modifications [158].  Briefly, a 
stock solution of HOCl was prepared by adding 1 ml of NaOCl solution to 40 ml of 154 mM 
NaCl and the pH was adjusted to around 3 by adding HCl.  The concentration of active total 
chlorine species in solution, expressed as [HOCl]T (where [HOCl]T = [HOCl] + [Cl2] + [Cl3−] + 
[OCl−]) in 154 mM NaCl, was determined by converting all the active chlorine species to OCl− 
by adding a bolus of 40 μl of 5 M NaOH and measuring the concentration of OCl−.  The 
concentration of OCl− was determined spectrophotometrically at 292 nm (ε = 362 M−1 cm 1).  As 
HOCl is unstable, the stock solution was prepared on a daily basis, stored on ice, and used within 
1 hr of preparation.  For further experimentation, dilutions were made from the stock solution 
using 200 mM phosphate buffer, pH 7, to give working solutions of lower HOCl concentrations. 
Melatonin solution 
A stock solution of MLT was dissolved in dimethylformamide (DMF) and then diluted to 
the required concentrations with phosphate buffer (pH = 7.00).  The concentration of DMF in all 
MLT solutions was less than 1% and did not interfere with MPO activity. 
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Results 
Melatonin prevents MPO inactivation by HOCl generated during MPO steady-state catalysis  
The ability of MLT to prevent HOCl damage to MPO catalytic activity was determined 
by two methods.  The first involved the use of an H2O2-selective electrode, which measured the 
first step in the MPO catalytic cycle in which H2O2 is consumed by MPO.  The second method 
measured HOCl –mediated MPO heme destruction utilizing UV-Visible and free iron release 
using ferrozine assay.  
The H2O2-selective electrode measurements revealed that addition of an aliquot of H2O2 
(10 µM; 3.5 µL) to the continuously stirred reaction solution supplemented with 40 nM MPO 
and 100 mM Cl- demonstrated an instant consumption of H2O2, as previously reported [156, 234, 
239].  Subsequent multiple additions of the same amount of H2O2 to the MPO/Cl- solution 
mixture caused MPO inhibition, as judged by the accumulation of H2O2 (amplitude of H2O2 
signal) and a slower rate of its consumption (longer duration) (Figure 14A).   
Figure 14. Melatonin 
inhibits MPO 
chlorination activity 
and prevents MPO 
heme destruction 
and iron release 
mediated by MPO 
self-generated HOCl. 
(A) A typical 
recording by an H2O2-
selective electrode 
demonstrating the 
dramatic MPO 
feedback inhibition 
mediated by self-
generated HOCl after 
addition of equal 
amounts of H2O2 (10 μM, 1–2 μl in 3 ml 
reaction mixture) five 
consecutive times (denoted by the arrows) to a continuously stirred phosphate buffer (200 mM, pH 7.4) containing 
40 nM MPO and 100 mM Cl−, at 25°C. (B) Similar experiment was repeated in the presence of MLT (100 μM), 
showing a significant protection of peroxidation activity of MPO. Under these circumstances, MLT inhibits the 
chlorinating activity of MPO and no heme destructions have been observed [81]. The data shown are representative 
of three independent experiments. 
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Under these circumstances, self-generated HOCl inhibited MPO through a mechanism 
that involves heme destruction, precluding the enzyme from functioning at maximum activity 
(80-90% inhibition) [70] (Figure 14A).  We used 40 nM MPO as the catalytic concentration.  
The pathophysiological effect of MPO was shown at concentrations of 5 nM [245].  To examine 
whether MLT could prevent the feedback heme destruction mediated by HOCl, an identical 
experiment was repeated in the presence of a saturating amount of MLT.  Addition of H2O2 (10 
μM) to a continuously stirred buffer solution supplemented with 40 nM MPO, 100 mM Cl-, and 
200 μM MLT caused a much slower rate of H2O2 consumption compared to control (Figure 
13B), which indicated that MLT inhibited the MPO catalytic activity [246].  The repeated 
addition of the same amounts of H2O2 to the MPO/Cl-/MLT reaction mixture showed that the 
degree of MPO inhibition remained the same for all of the five trials.  Thus under these 
conditions, MLT protected the peroxidation activity of MPO, but inhibited the chlorinating 
activity of the enzyme by serving as 1 e- substrate for both MPO compounds I and II [81].  
We next performed UV-visible photometry to correlate the degree of catalytic inhibition 
with HOCl-mediated heme destruction.   
Figure 15. Melatonin prevents MPO 
heme destruction mediated by self-
generated HOCl during steady state 
catalysis. Fixed amount of MPO (1 μM) 
was incubated with fixed amount of Cl-  
(100 mM) and increasing concentration 
of MLT (12 -200 μM), and the reaction 
mixtures were incrementally received 
fixed amount of H2O2 (20 μM,  total 
concentration of 180 μM).  After reaction 
completion, the spectra of the reaction 
mixtures were scanned from 300 - 700 
nm. The percent recovery in MPO Soret 
peak (430 nm) plotted as a function of 
melatonin concentration.  The full 
protection of the MPO heme contents 
required the presence of a ratio 1: 2 
MLT: H2O2.  The inset shows the absorbance spectra of MPO ferric form before (blue trace) and after the last 
incremental addition of H2O2 (red trace).  The flattening in the MPO spectrum indicates MPO heme destruction.  
The data points are the average of three independent experiments. 
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As shown in the Figure. 15 inset; blue trace, MPO-Fe(III) as isolated displays a Soret 
absorbance peak centered at 430 nm, with three additional beaks at 573, 630, and 694 nm.  Since 
the addition of a high molar ratio of H2O2 to MPO causes the conversion of MPO to Compound 
(III) (MPO-FeII-O2 complex) [247], the oxidation of the MPO heme moiety mediated by self-
generated HOCl was monitored by sequential addition of H2O2 (20 μM; 3 μl) (180 μM H2O2 
total) to the MPO-Fe(III)/Cl− mixture.  With each incremental addition of H2O2, there was a 
proportional decrease in the MPO Soret peak, indicating that HOCl-mediated MPO feedback 
inhibition is associated with MPO heme destruction.  After the last addition of H2O2 (180 μM 
total) solution to enzyme mixture, the spectrum recording showed a flattening in the Soret peak 
at 430 nm indicating MPO heme destruction (Figure 15 inset; red trace).  This flattening in the 
Soret peak region occurred solely in the presence of Cl−, signifying HOCl to be the major cause 
of MPO heme destruction.  To confirm that MLT prevents HOCl-mediated MPO heme 
destruction, a fixed amount of MPO/Cl− mixture was preincubated with increasing 
concentrations of MLT prior to incremental additions of H2O2 to the reaction mixture.  Figure 15 
shows the percentage recovery of MPO heme content, measured at 430 nm after the last addition 
of the incremental H2O2 to the enzyme solution, as a function of MLT concentration.  In the 
presence of a saturating amount of MLT (>100 μM), spectral analysis indicated no losses in the 
heme content.  Under these conditions, the MPO- H2O2 system utilized MLT as a 1e- substrate 
for the formation and subsequent decay of Compound II.  The accumulation and stability of 
MPO Compound II (characterized by a Soret absorbance peak at 450 nm) during catalysis 
depended on the MLT concentration.  In the presence of lower MLT levels, addition of limiting 
amounts of H2O2 (10 µM) to the solution mixture caused immediate appearance of MPO 
Compound II, which then decayed to the ferric form in the next few seconds.  In the presence of 
higher MLT concentrations (e.g. 100-400 µM), no significant change in absorbance was 
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observed upon the addition of an H2O2 solution to the MPO mixture, indicating that the rate of 
MPO compound II decay exceeded the rate of formation, which was consistent with previous 
results [248].  In the presence of 50 µM MLT, only 50% recovery was noted in the MPO Soret 
absorbance peak of the total enzyme.  As shown in Figure. 15, the full protection of the MPO 
heme contents required the presence of a ratio 1:2 MLT: H2O2 ratio.  Collectively, our results 
showed that heme destruction did not occur in the presence of MLT, where MPO began reducing 
H2O2 without generating HOCl, indicating that self-generated HOCl is the major cause of MPO 
inactivation. 
To investigate how the flattening in the Soret absorbance peak at 430 nm in H2O2-treated 
samples, is linked to MPO heme depletion, and if MLT can prevent this finding, we studied the 
free iron release after H2O2 treatment in the absence and presence of saturating amounts of MLT.  
By comparing to the free iron content of the untreated control, treatment with H2O2 led to a 
significant increase in free iron content as compared to control (Figure 16).  
Figure 16. Melatonin prevents 
HOCl mediated MPO heme 
destruction and subsequent 
free iron release during MPO 
catalysis.  MPO (1.2 µM) was 
incubated with 100 mM Cl− in 
the absence and presence of 400 
µM MLT followed by the 
addition of aliquots of H2O2 (in 
increments of 20 µM) to the 
reaction mixture. The free iron 
released was measured using 
ferrozine assay as detailed under 
Materials and methods. No free 
iron was detected before the 
addition of H2O2. The data are 
the averages of three independent 
experiments with the error bars 
representing the standard error of 
measurement.  
 
Additionally, in the same figure, we noted around 25% free iron detection.  This finding 
is likely secondary to the fact that not all iron was detached from the heme fragments, and 
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therefore not able to be detected by the assay.  The accumulation of free iron significantly 
decreased in the presence of saturating amounts of MLT, confirming the above 
spectrophotometric studies.  Thus, MLT not only inhibits MPO catalytic activity, but also 
prevents heme destruction and subsequent free iron release mediated by self-generated HOCl. 
The protection of MPO heme destruction mediated by self-generated HOCl occurred at the 
expense of melatonin oxidation 
Finally, HPLC analysis (anion exchange) was utilized to investigate in depth the 
mechanism by which MLT presence prevents MPO heme 
destruction mediated by self-generated HOCl.  Using this 
method, we observe an accumulation of two major MLT 
metabolites when concentrations of MLT used were 
sufficient to produce dramatic effects on the rates of 
Compound II formation, duration, and decay.  The 
population of these metabolites is varied and depending 
on the H2O2 concentration used (Figure 17).   
 
 
 
Figure 17: HPLC analysis shows MLT oxidation thereby 
preventing MPO heme destruction and generation of free iron. 
A) HPLC trace for MLT (elution time 3.98 min) dissolved in DMF 
(elution time 3.31 min) and phosphate buffer (elution time 2.48 min). 
B) Addition of MPO and Cl- causes no significant change in MLT 
peak intensity and/or retention time. C) Addition of H2O2 (sequential 
addition of 20 µM, total 200 µM) results in a significant shift in 
MLT retention time elution time (3.71 min) as well as the 
appearance of a small peak around 3.57 min. D) Increasing levels of 
H2O2 (400 µM) resulted in the domination of the MLT metabolite 
eluted at 3.57 min showing the retention and absorbance properties 
of AFMK (elution time 3.57 min) as shown in panel (E).  
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HPLC analyses were conducted under five different conditions: MLT alone; MPO (40 
nM) pre-incubated with MLT (100 µM) alone; the solution mixture of MPO pre-incubated with 
MLT (100 µM) which received sequential additions of 20 µM H2O2 (to total either 200 or 400 
µM H2O2); and finally AFMK alone.  After reaction completion, the reaction mixtures were 
filtered to eliminate MPO and the supernatants were then injected into the HPLC system.  Under 
our experimental conditions phosphate buffer and DMF were eluted at 2.48 and 3.31 min, 
respectively (Figure 17).  MLT alone was eluted at 3.95 min (Figure 17A) while AFMK alone 
was eluted at 3.57 min (Figure 17E), and both were identified by their characteristic spectra 
observed from the photodiode array detector at 222 and 236 nm, respectively.  Pre-incubation of 
MLT (100 µM) with a catalytic amount of MPO (40 nM) and Cl- (100 mM), in the absence of 
H2O2, fails to generate any detectable MLT metabolite (Figure 17B).  HPLC analysis also 
indicated that relatively short time incubation of H2O2 at the different concentrations employed 
(200-400 µM) in the experiment for 2h has no effect on the MLT (100 µM) moiety (data not 
shown).  However, long incubation of high concentration of H2O2 (30%) with MLT in the 
presence of methanol generates AFMK (Figure 17E) [244].  
However, incremental addition of H2O2 to the enzyme- MLT mixture resulted in MLT 
oxidation to a lower elution time indicating formation of MLT metabolites with lower 
hydrophobicity.  The enzyme sample that was pre-incubated with 100 µM MLT and treated with 
200 µM H2O2 (total) led to the production of two main MLT metabolites with elution times of 
3.71 and 3.57 min with the first being the most abundant and attributed to the formation of 
hydroxyl melatonin metabolite (Figure 17C).  Although we provide no direct evidence for the 
hydroxyl melatonin formation, we do note corresponding 1e- heme reduction steps for MPO 
Compounds I and II in the presence of MLT.  The MPO sample that was incubated with 100 µM 
MLT and treated with 400 µM H2O2 (total) led to the production of a MLT metabolite with 
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elution time of 3.57 min, which was similar to elution time of AFMK alone (Figure. 17D).  
Consistent with these studies, Ximenes et al. similarly have observed two MLT metabolites 
(hydroxyl melatonin and AFMK) when MLT was incubated with MPO-H2O2 system or with 
stimulated neutrophils [249].  Thus, MLT prevents MPO heme destruction either by directly 
scavenging HOCl and/or inhibiting MPO chlorinating activity.   
Discussion  
In this work, we show that MLT largely prevents MPO catalytic inhibition, attributed to 
MPO heme destruction and the generation of free iron associated with HOCl synthesis, through 
its function as a potent MPO inhibitor and/or a HOCl scavenger.  Thus, MLT may contribute to 
the reduction of the inflammatory process not only by inhibiting MPO and consuming HOCl, but 
also by diminishing the release and accumulation of free iron.   
Recently, we have characterized an irreversible inhibition that is related to MPO heme 
destruction and the generation of free iron, when appropriate concentrations of self-generated 
HOCl are reached in the enzyme milieu [70].  These findings were recently confirmed by 
Paumann-Page et al [250].  The accumulation of the released HOCl in the solution mixture 
permits the competition with H2O2 on the catalytic site of MPO, which is in this case is the heme 
prosthetic group [70].  Hypochlorous acid interacts with both MPO-Fe(III) and Compound I and 
accelerates their conversion to Compound II [70, 251], or forms a relatively stable MPO-Fe(III)-
OCl complex, which also converts to Compound II prior to heme destruction [70].  Compound II 
is a long-lived intermediate so would be predominantly susceptible to HOCl assault leading to 
heme destruction [57].  In the absence of an MPO inhibitor, HOCl scavenger, or both, the degree 
of MPO heme destruction is significantly high in that only a small portion of the total enzyme (5-
10%) is estimated to remain active after multiple cycles of HOCl synthesis [229].  Our current 
results demonstrate that the degree of MPO heme pocket alterations (e.g., by changes in the 
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hydrogen bonds) mediated by MLT is not only sufficient to affect the interaction of Compound I 
with Cl- preventing the generation of HOCl, but also prevents HOCl access to the heme moiety; 
thereby avoiding HOCl-dependent heme destruction.  These notions are consistent with our 
previous detailed kinetic studies, which showed the ability of MLT to inhibit MPO chlorinating 
activity despite the presence of high concentrations of Cl- [81].  Melatonin competes with Cl- and 
switches the MPO catalytic activity from a 2e- oxidation to a 1e- oxidation pathway.  Under these 
conditions, MPO did not generate HOCl but still consumed H2O2 at slower rates. H2O2-selective 
measurements showed that MLT presence inhibits MPO peroxidase activity.  This observation 
appears relevant even in the presence of alternative substrates because peroxidases like MPO are 
not saturated under physiological conditions [252].  These notions are also supported by 
theoretical modeling, which showed that indole compounds could be accommodated in the 
narrow regions of the active site pockets of MPO when the indole ring is situated parallel to the 
heme plane and close enough to the D pyrrole ring.  Under the circumstances the side chain of 
the indole compound is directed toward the outside of the distal cavity [253].  
It is clear from the MLT presence that the MPO chlorinating activity, but not H2O2, is 
implicated in MPO heme destruction and free iron release.  This conclusion is consistent with 
previous studies by Paumann-Page et al. who showed that the MPO inactivation mediated by 
H2O2 is unlikely to take place in the presence of reducing substrates (100 mM Cl-), and where the 
concentration of H2O2 does not accumulate [254].  The amount of MLT used (100 µM) in the 
current work is sufficient to inhibit MPO.  Studies on the effect of MLT on HOCl production by 
neutrophils and purified MPO have showed that the concentration of MLT that inhibited HOCl 
production by 50% (IC50) was estimated to be 18 μM and reduced to 4 μM when superoxide was 
removed by addition of superoxide dismutase [249].  In contrast, the IC50 value, calculated from 
the initial rate of H2O2 consumption, as a function of the MLT concentration was 3 μM [81]. Our 
61 
 
HPLC analysis showed that the protection of MPO heme destruction mediated by self-generated 
HOCl occurred at the expense of MLT oxidation, which depends on the concentration of H2O2 
used.  Ximenes et al. showed the elution of two MLT metabolites when MLT was exposed to 
neutrophils [249]. In their system, the major and minor peaks were AFMK and a hydroxlyated 
melatonin metabolite, respectively.  We similarly observed 2 peaks in our system; however, we 
believe the major peak was the hydroxylated intermediate when a lower concentration of H2O2 
(1:2, MLT: H2O2) was used.  In contrast, AFMK predominated when MPO was exposed to 
higher concentrations of H2O2 (1:4, MLT: H2O2).  This alteration in the peroxidation turnover 
resulted in the reversal of the populations of the two MLT metabolites.  Thus, prevention of 
MPO heme destruction depends on multiple factors including the bioavailability of HOCl, the 
presence of a capable 1e- substrate that can compete with Cl- switching the reaction from a 2e- to 
a 1e- oxidation pathway (e.g. ascorbic acid, superoxide, and nitric oxide), and the presence of 
HOCl scavengers. 
Melatonin prevention of HOCl-mediated heme destruction is not limited to MPO, but 
also applies to other hemoprotein model compounds, such as hemoglobin, lactoperoxidase, 
catalase, as well as isolated human red blood cells [57, 70, 238, 249, 255, 256].  Earlier kinetic 
measurements have indicated that HOCl initially mediates the sequential formation of ferryl 
peroxidase-like intermediates, compounds I and II, followed by heme degradation [70, 238, 251, 
257].  Hypochlorous acid can also mediate tetrapyrrole ring destruction independent of the iron 
molecule that resides in the porphyrin center [57].  A general chemical mechanism that describes 
the tetrapyrrole ring destruction resulting from the direct attack of HOCl and generation of 
multiple heme degradation products is well documented [57, 185, 228, 229, 238].  Because of 
MLT's ability to inhibit MPO, destabilize the Compound II intermediate and/or directly scavenge 
HOCl, MLT could be considered an ideal component for prevention against HOCl mediated 
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oxidative damage. 
Although experiments that utilized methionine or taurine as scavenger of HOCl showed 
that they could prevent HOCl-mediated MPO heme destruction [104] similar to MLT, there are 
important differences in the fundamental aspects.  Melatonin and its precursors, unlike other 
HOCl scavengers, display a high affinity towards transition metal (e.g. iron (III), copper and 
zinc) binding, and subsequently reduce their cytoplasmic availability [108-110].  In addition, 
several in vivo studies have shown that administration of MLT directly or indirectly neutralizes a 
variety of ROS, resulting in the reduction of lipid peroxidation, protein oxidation, and DNA 
damage, thus helping the immune system [51, 108, 109, 258, 259].  One other factor that 
distinguishes MLT from other HOCl scavengers (e.g. taurine, cystine, cysteine and uric acid) is 
that its oxidation products have no biologically harmful sequelae [104, 105].  Melatonin reacts 
with HOCl to produce 2-hydroxymelatonin [47] at a rate sufficient to protect catalase against 
inactivation by this molecule [260].  Melatonin’s presence during MPO catalysis is associated 
with a significant diminution of free iron release, decrease in the intensity of the fluorescent 
heme degradation products, and reduction in different profiles of protein aggregation [47].  In 
contrast, taurine reacts with HOCl to form a less active oxidant taurine chloramine.  It is 
important, however, to note that while chloramines are less reactive than HOCl, they can still 
oxidize thiols, thioethers and heme proteins, and thus extend the reactivity of HOCl [105-107].  
The association between enhanced MPO expression and increased levels of free iron is 
characteristic of many inflammatory disorders including cardiovascular diseases such 
atherosclerosis, pulmonary diseases such as cystic fibrosis, neurodegenerative diseases such as 
Alzheimer’s disease as well as arthritis, diabetes, and has been found to be risk factor for various 
cancers [15, 21, 236, 237, 261-265].  As free iron accumulates, it disturbs body processes by 
replacing certain vital minerals such as zinc, copper, and manganese in many enzymes, depleting 
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vitamins such as vitamin E and D, and may lead to chronic infection, and inflammation [266].  
Due to its properties as an excellent oxygen transporter, iron tends to stimulate the growth of 
tumor cells and bacteria [267, 268].  Therefore, blocking the MPO chlorination machinery 
(MLT, tryptophan, and   tryptophan analogs) [81, 156, 239] or scavenging HOCl (MLT, 
methionine, lycopine, taurine, and glutathione) might be a useful therapeutic approach in 
reducing free iron release in a wide variety of inflammatory conditions.  
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CHAPTER 5 
CONCLUSIONS 
This work is the first to link the effect of activated macrophages, simulating 
inflammation, through a mechanism involving MPO catalytic activity and ROS generation with 
the deterioration in the oocyte quality, which may contribute to poor reproductive outcome. 
Our results from the Chapter 2 definitively confirm the deleterious effect of increasing 
ROS concentration on oocyte quality.  Importantly, the supportive surrounding cumulus cells 
armed with antioxidant machinery showed variable ability to protect oocyte quality against ROS 
assault.  Cumulus cells showed limited protection against H2O2 and •OH insult at low 
concentrations, however they lost their ability to protect at higher concentrations.  Moreover, 
cumulus cells offered no significant protection to the oocyte against HOCl at any concentration.  
Further investigation of these findings indicate that ROS compromise cumulus cell function by 
decreasing both cell number and viability, which is ultimately associated with the loss of oocyte 
viability.  
Reactive oxygen species are known to be alternatively generated through the catalytic 
activity of MPO, which is synthesized and secreted from activated macrophages.  In Chapter 3 
we successfully showed the impact of activated macrophages on oocyte quality, which mirrored 
and then exceeded the impact of purified MPO, in a time dependent fashion.  Similarly, HOCl, 
the MPO related oxidant also deteriorated oocyte quality irrespective of cumulus cells presence 
(please see Chapter 2 results).  Melatonin showed a powerful protective ability against MPO, 
either purified or naturally secreted from activated macrophages, and against ROS by 
functioning as a potent inhibitor of MPO chlorinating activity and ROS scavenger.  
Recent studies demonstrated that MPO is the major source of HOCl as well as free iron 
release under a HOCl feedback mechanism, which degraded the heme-ring in MPO.  Under these 
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conditions, free iron reacts with H2O2, through a known Fenton reaction, generates •OH, thus 
worsening the oocyte microenvironment.  Further research has found that the intra-oocyte H2O2 
diffuses to the extracellular environment of the oocyte activating MPO and deteriorating oocyte 
quality.  It is highly likely that HOCl is generated in the oocyte–macrophages culture media (see 
Chapter 3) and mediates oocyte quality deterioration.     
Chapter 4 elucidated the mechanism of HOCl generation through the MPO catalytic 
system and confirmed that generated HOCl has the ability to oxidize and thus consume MLT, as 
judged by the appearance of the melatonin intermediates utilizing HPLC analysis.  Briefly, we 
have described, in the absence of any inhibitor or scavenger, that sufficient amounts of self-
generated HOCl have the ability to irreversibly inhibit MPO activity by destroying the heme 
moiety of the MPO molecule and subsequently generate free iron.  While repeating the 
experiment in the presence of MLT, we found that melatonin can with Cl- and interact with 
Complex I to obstruct MPO chlorinating ability and prevent HOCl generation.  Melatonin also 
acts as a direct HOCl scavenger and therefore prevents HOCl accumulation thereby avoiding 
HOCl-mediated MPO heme destruction.  Furthermore, using ferrozine assays we revealed that 
the accumulation of free iron significantly decreased in the presence of MLT (see Chapter 3).  
Therefore, MLT preserves MPO peroxidation activity (by consuming H2O2 at slower rates) and 
prevents further oxidant generation and free iron release.  This study is important because we are 
the first to link activated macrophages, a major source of MPO, with oocyte quality 
deterioration, highlighting the effects of activated macrophages in infertility caused by 
inflammation.  As MLT can disable and scavenge MPO, and displays beneficial therapeutic 
effects in preserving oocyte quality, it may improve reproductive outcomes in patients with 
chronic inflammation. 
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License Terms and Conditions-Reproductive Sciences 
(Chapter 1) 
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License Terms and Conditions-PLOS  
(Chapter 3) 
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Inflammatory reactions mediated by oxidative stress (OS) have been implicated in the 
deterioration of oocyte quality, which may lead to subfertility.  Oxidative stress generated from 
enhancement of activated macrophages secondary to an inflammatory response are the major 
source of reactive oxygen species (ROS) such as superoxide (O2•−), hydrogen peroxide (H2O2), 
hydroxyl radical (•OH), and hypochlorous acid (HOCl), as well as, the pro-inflammatory enzyme 
myeloperoxidase (MPO).  Previously, it has been shown that these ROS have deleterious effect 
on oocytes; however the link between inflammation through macrophage activity and oocyte 
quality remains unclear.  In this work, we investigated: 1) the mechanism through which direct 
exposure of ROS and MPO, or through their generation by activated macrophages, deteriorate 
oocyte quality and whether melatonin (MLT), a potent MPO inhibitor and ROS scavenger, can 
protect oocyte quality; and 2) the mechanism through which MLT inhibits MPO catalytic 
activity. 
Our results indicated that ROS differentially deteriorate oocyte quality in a dose 
dependent manner possibly secondary to the overwhelming of the defense antioxidant capacity 
of the cumulus oocyte complex (COC).  Cumulus cells demonstrated protection against H2O2 
and •OH insult at low concentrations, but this protection was lost at higher concentrations and all 
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concentrations of HOCl as judged by changes in the organized compact cumulus cell mass into a 
dispersed mass of cells with decreased cumulus cell number and viability.  Therefore, increasing 
ROS concentration overpowered the antioxidant machinery provided by the oocyte and /or 
cumulus cells, through loss of cumulus cells, or the lack of scavengers for specific ROS.  This 
mechanism of damage may be associated with infertility related to COC dysfunction and thus 
deterioration in oocyte quality. 
Myeloperoxidase as well as activated macrophages negatively affected oocyte quality in 
a time dependent fashion. In all circumstances cumulus cells did not offer protection to the 
oocyte; however significant protection was offered by MLT.  Kinetic studies have shown that 
MLT inhibits the MPO chlorinating (generation of HOCl) activity through its ability to compete 
with Cl-, the natural substrate of MPO, and serve as a one electron substrate of MPO Compounds 
I and II.  Thus, MLT preserves the MPO peroxidation activity (by consuming H2O2 at slower 
rates) without the generation of HOCl through a two-step one-electron (1e−) oxidation pathway.   
This study is the first to link activated macrophages, a major source of MPO and ROS, 
and oocyte quality deterioration, highlighting the effects of activated macrophages in infertility 
caused by inflammation.  MLT has beneficial therapeutic effects in preserving oocyte quality, 
thus improving reproductive outcomes in patients with chronic inflammation.   
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